<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0803233343
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2017
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        TAGRISSO 80 mg Film-Coated Tablet
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        OSIMERTINIB MESILATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        80
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        28409.90
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="AstraZeneca" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            AstraZeneca
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 583]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ALNAGHI COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            AstraZeneca
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        L01XE35
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>TAGRISSO contains the active substance osimertinib, which belongs to a group of medicines called protein kinase inhibitors which are used to treat cancer. TAGRISSO is used to treat adults with a type of lung cancer called &lsquo;non-small cell lung cancer.&rsquo; If a test has shown that your cancer has certain changes (mutations) in a gene called &lsquo;EGFR&rsquo; (epidermal growth factor receptor) your cancer is likely to respond to treatment with TAGRISSO.</p><p>&nbsp;</p><p>TAGRISSO alone can be prescribed for you:</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to help prevent your lung cancer from coming back after your tumour(s) has been removed by surgery, <strong>or</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; when your lung cancer has spread to nearby tissues (locally advanced) that is unable to be removed (unresectable) by surgery and has responded or stabilized following chemotherapy and radiation treatment, <strong>or</strong></p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; as your first treatment when your lung cancer has spread to other parts of the body (metastatic), <strong>or</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; when your lung cancer has spread to other parts of the body (metastatic) and you have had previous treatment with an EGFR tyrosine kinase inhibitor (TKI) medicine that did not work or is no longer working.</p><p>&nbsp;</p><p>TAGRISSO can be prescribed for you, in combination with other anti-cancer medicines, including:</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; in combination with pemetrexed and platinum-based chemotherapy, as your first treatment when your lung cancer has spread to nearby tissues (locally advanced) or to other parts of the body (metastatic).</p><p>When TAGRISSO is given in combination with other anti-cancer medicines, it is important that you also read the package leaflet for these other medicines. If you have any questions about these medicines, ask your doctor.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>How TAGRISSO</strong> <strong>works</strong></p><p>&nbsp;</p><p>TAGRISSO works by blocking EGFR and may help to slow or stop your lung cancer from growing. It may also help to reduce the size of the tumour and prevent the tumour from coming back after removal by surgery.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are receiving TAGRISSO after complete removal of your cancer, it means that your cancer contained defects in the EGFR gene, &lsquo;exon 19 deletion&rsquo; or &lsquo;exon 21 substitution mutation&rsquo;.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If TAGRISSO is the first protein kinase inhibitor medicine you are receiving, it means that your cancer contains defects in the EGFR gene, for example &lsquo;exon 19 deletion&rsquo; or &lsquo;exon 21 substitution mutation&rsquo;.&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If your cancer has progressed while you were being treated with other protein kinase inhibitor medicines, it means that your cancer contains a gene defect called &lsquo;T790M&rsquo;. Because of this defect, other protein kinase medicines may no longer work.</p><p>If you have any questions about how this medicine works or why this medicine has been prescribed for you, ask your doctor.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take TAGRISSO</strong> <strong>if:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you are allergic (hypersensitive) to Osimertinib or any of the other ingredients of this medicine (listed in section 6).</p><p>&nbsp;</p><p>If you are not sure, talk to your doctor, pharmacist or nurse before taking TAGRISSO.</p><p>&nbsp;</p><p><strong>Warnings and precautions</strong></p><p>&nbsp;</p><p>Talk to your doctor, pharmacist or nurse before taking TAGRISSO if:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have suffered from inflammation of your lungs (a condition called &lsquo;interstitial lung disease&rsquo;).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have ever had heart problems &ndash; your doctor may want to keep a close eye on you.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have a history of eye problems.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have Skin problems.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have Inflammation of the blood vessels in your skin.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have Blood and bone marrow problems.</p><p>&nbsp;</p><p>If any of the above apply to you (or you are not sure), talk to your doctor, pharmacist or nurse before taking this medicine.</p><p>&nbsp;</p><p><strong>Tell your doctor straight away while taking this medicine if:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have sudden difficulty in breathing together with a cough or fever.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have unusually pale skin .</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have watery eyes, sensitivity to light, eye pain, eye redness or vision changes.</p><p>See &lsquo;Serious side effects&rsquo; in section 4 for more information.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you develop persistent fever, bruising or bleeding more easily, increasing tiredness, pale skin and infection. See &lsquo;Serious side effects&rsquo; in section 4 for more information.</p><p>&nbsp;</p><p><strong>Children and adolescents</strong></p><p>TAGRISSO has not been studied in children or adolescents. Do not give this medicine to children or adolescents under the age of 18 years.</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>Other medicines and TAGRISSO</strong></p><p>&nbsp;</p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes herbal medicines and medicines obtained without a prescription. This is because TAGRISSO can affect the way some other medicines work. Also some other medicines can affect the way TAGRISSO works.</p><p>&nbsp;</p><p><strong>Tell your doctor before taking TAGRISSO </strong><strong>if you are taking any of the following medicines:</strong></p><p>&nbsp;</p><p>The following medicines may reduce how well TAGRISSO works:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Phenytoin, carbamazepine or phenobarbital &ndash; used for seizures or fits.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rifabutin or rifampicin &ndash; used for tuberculosis (TB).</p><p>&nbsp;</p><p>TAGRISSO may affect how well the following medicines work and/or increase side effects of these medicines:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rosuvastatin &ndash; used to lower cholesterol.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Oral hormonal contraceptive pill&ndash; used to prevent pregnancy.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bosentan &ndash; used for high blood pressure in the lungs.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Efavirenz and etravirine &ndash; used to treat HIV infections/AIDS.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Modafinil &ndash; used for sleep disorders.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dabigatran &ndash; used to prevent blood clots.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Digoxin &ndash; used for irregular heart beat or other heart problems.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aliskiren &ndash; used for high blood pressure.</p><p>&nbsp;</p><p><strong>If you are taking any of the medicines listed above, tell your doctor before taking TAGRISSO</strong><strong>. </strong>Your doctor will discuss appropriate treatment options with you.</p><p>&nbsp;</p><p><strong>Pregnancy </strong>&ndash;<strong> information for women</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; are pregnant or plan to become pregnant. TAGRISSO can harm your unborn baby. Tell your healthcare provider right away if you become pregnant during treatment with TAGRISSO or think you may be pregnant</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; who are able to become pregnant should have a pregnancy test before starting treatment with TAGRISSO. You should use effective birth control (contraception) during treatment with TAGRISSO and for 6 weeks after the last dose of TAGRISSO</p><p>&nbsp;</p><p><strong>Pregnancy </strong>&ndash;<strong> information for men</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; who have female partners that are able to become pregnant should use effective birth control during treatment with TAGRISSO and for 4 months after the last dose of TAGRISSO</p><p>&nbsp;</p><p><strong>Contraception </strong>&ndash;<strong> information for women and men</strong></p><p>You must use effective contraception during treatment.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TAGRISSO may interfere with how well oral hormonal contraceptives work. Discuss with your doctor the most appropriate methods of contraception.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TAGRISSO may pass into semen. Therefore, it is important that men also use effective contraception.</p><p>&nbsp;</p><p>You must also do this after completing treatment with TAGRISSO:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Women</strong> &ndash; keep using contraception for 2 months after.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Men </strong>&ndash; keep using contraception for 4 months after.</p><p>&nbsp;</p><p><strong>Breast-feeding</strong></p><p>Do not breast-feed while taking this medicine. This is because it is not known if there is a risk to your baby.</p><p>&nbsp;</p><p><strong>Driving and using machines</strong></p><p>TAGRISSO has no or no marked influence on the ability to drive and use machines.</p><p>&nbsp;</p><p><strong>TAGRISSO contains sodium </strong></p><p>This medicine contains less than 1&nbsp;mmol sodium (23&nbsp;mg) per tablet, that is to say essentially &ldquo;sodium-free&rdquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><p>&nbsp;</p><p><strong>How much to take</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Take TAGRISSO exactly as your healthcare provider tells you to take it.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Your healthcare provider may change your dose, temporarily stop, or permanently stop treatment with TAGRISSO if you have side effects.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Take TAGRISSO 1 time each day.</p><p>&nbsp;</p><p><strong>How to take</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TAGRISSO is taken by mouth. Swallow the tablet whole with water. Do not crush, split or chew the tablet.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Take TAGRISSO every day at the same time.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; You can take this medicine with or without food.</p><p>&nbsp;</p><p>If you have trouble swallowing the tablet, you can mix it in water:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Place your dose of TAGRISSO in a container that contains 60 mL (2 ounces) of water. Do not use carbonated water or any other liquids.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stir the TAGRISSO tablet and water until the TAGRISSO tablet is in small pieces (the tablet will not completely dissolve). Do not crush, heat, or use ultrasound to prepare the mixture.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Drink the TAGRISSO and water mixture right away.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Add 120 mL to 240 mL (4 to 8 ounces) of water into the container and drink to make sure that you take your full dose of TAGRISSO.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>If you have a nasogastric (NG) tube:</strong></p><p>o&nbsp;&nbsp; Follow the same instructions for mixing TAGRISSO tablets in a container that contains 15 mL of water. <strong>Do not</strong> use carbonated water or any other liquids.</p><p>o&nbsp;&nbsp; Stir the TAGRISSO tablets and water until the TAGRISSO tablets are in small pieces (the tablets will not completely dissolve). Do not crush, heat, or use ultrasound to prepare the mixture.</p><p>o&nbsp;&nbsp; Add another 15 mL of water into the container to make sure no pieces of TAGRISSO tablet remain.</p><p>o&nbsp;&nbsp; Give the TAGRISSO tablet and water mixture using the NG tube manufacturer instructions within 30 minutes.</p><p>Add another 30 mL of water into the syringe and give the water and any remaining TAGRISSO through the NG tube to make sure that all of the medicine is given. Repeat this step until no pieces remain in the syringe. This will help to ensure that the full prescribed dose of the TAGRISSO is given.</p><p>&nbsp;</p><p><strong>If you take more TAGRISSO</strong> <strong>than you should</strong></p><p>If you take more than your normal dose, contact your doctor or nearest hospital straight away.</p><p>&nbsp;</p><p><strong>If you forget to take TAGRISSO</strong></p><p>If you miss a dose of TAGRISSO, do not make up for the missed dose. Take your next dose at your regular time.</p><p>&nbsp;</p><p><strong>If you stop taking TAGRISSO</strong></p><p>Do not stop taking this medicine - talk to your doctor first. It is important to take this medicine every day, for as long as your doctor prescribes it for you.</p><p>&nbsp;</p><p>If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>&nbsp;</p><p><strong>Serious side effects</strong></p><p>Tell your doctor straight away if you notice any of the following serious side effects (see also section 2):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Lung problems.</strong> TAGRISSO may cause severe lung problems that may lead to death. Symptoms may be similar to those symptoms from lung cancer. Tell your healthcare provider right away if you have any new or worsening lung symptoms, including trouble breathing, shortness of breath, cough, or fever.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Heart problems, including heart failure.</strong> TAGRISSO may cause heart problems that may lead to death. Your healthcare provider should check your heart function before you start taking TAGRISSO and during treatment as needed. Tell your healthcare provider right away if you have any of the following signs and symptoms of a heart problem: feeling like your heart is pounding or racing, shortness of breath, swelling of your ankles and feet, dizziness, feeling lightheaded, or feeling faint.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Eye problems. </strong>TAGRISSO may cause eye problems. Tell your healthcare provider right away if you have symptoms of eye problems which may include watery eyes, sensitivity to light, eye pain, eye redness, or vision changes. Your healthcare provider may send you to see an eye specialist (ophthalmologist) if you get eye problems with TAGRISSO.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Skin problems. </strong>TAGRISSO may cause skin problems. Tell your healthcare provider right away if you develop skin reactions that look like rings (target lesions), severe blistering or peeling of the skin.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Inflammation of the blood vessels in your skin</strong>. TAGRISSO may cause blood vessel problems in your skin. Tell your healthcare provider right away if you develop purple spots or redness of the skin that does not fade in color when pressed (non-blanching) on your lower arms, lower legs, or buttocks or large hives on the main part of your body (trunk) that do not go away within 24 hours and look bruised.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Blood and bone marrow problems</strong>. TAGRISSO may cause a condition where your bone marrow cannot make enough new blood cells (aplastic anemia), and which may lead to death. Your healthcare provider will monitor your blood cell counts before you start and during treatment with TAGRISSO. <strong>Tell your healthcare provider right away</strong> if you develop any signs or symptoms of blood and bone marrow problems, including:</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><ul><li>a new fever or fever that does not go away (temperature 100.4&deg;F or higher)</li></ul></td><td style="vertical-align:top"><ul><li>easy bruising or bleeding that will not stop</li><li>unusually pale skin</li></ul></td><td style="vertical-align:top"><ul><li>infection</li><li>tiredness</li><li>weakness</li></ul></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p><strong>Other side effects</strong></p><p><strong>Very common </strong>(may affect more than 1 in 10 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diarrhoea - this may come and go during treatment. Tell your doctor if your diarrhoea does not go away or becomes severe.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Skin and nail problems - signs may include pain, itching, dry skin, rash, redness around the fingernails. This is more likely in areas exposed to the sun. Using moisturisers regularly on your skin and nails can help with this. Tell your doctor if your skin or nail problems get worse.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stomatitis - inflammation of the inner lining of the mouth or ulcers forming in the mouth.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loss of appetite.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reduction in the number of white blood cells (leukocytes, lymphocytes or neutrophils).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reduction in the number of platelets in the blood.</p><p>&nbsp;</p><p><strong>Common </strong>(may affect up to 1 in 10 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nose bleed (epistaxis).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hair thinning (alopecia).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hives (urticaria) - itchy, raised patches anywhere on the skin, which may be pink or red and round in shape. Tell your doctor if you notice this side effect.</p><p><s>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </s>Hand-foot syndrome &ndash; this may include redness, swelling, tingling or burning sensation with cracking of the skin on the palms of hands and/or soles of feet.</p><p><s>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </s>Increase of a substance in the blood called creatinine (produced by your body and removed by the kidney).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase of a substance in the blood called creatine phosphokinase (an enzyme released into the blood when muscle is damaged).</p><p>&nbsp;</p><p><strong>Uncommon</strong> (may affect up to 1 in 100 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Target lesions, which are skin reactions that look like rings (suggestive of Erythema multiforme).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the blood vessels in the skin. This may give the appearance of bruising or redness of the skin that does not fade in colour when pressed (non-blanching).</p><p>&nbsp;</p><p><strong>Rare</strong> (may affect up to 1 in 1000 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammation of the muscle which may result in muscle pain or weakness</p><p>&nbsp;</p><p>The following side effects <strong>of TAGRISSO in combination with pemetrexed and platinum-based chemotherapy include</strong>:</p><p><strong>&nbsp;</strong></p><p><strong>Very common </strong>(may affect more than 1 in 10 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diarrhoea &ndash; this may come and go during treatment. Tell your doctor if your diarrhoea does not go away or becomes severe.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Skin and nail problems - signs may include itching, dry skin, rash, redness around the fingernails. Using moisturisers regularly on your skin and nails can help with this. Tell your doctor if your skin or nail problems get worse.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stomatitis &ndash; inflammation of the inner lining of the mouth or ulcers forming in the mouth.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reduction in the number of white blood cells (leukocytes, lymphocytes or neutrophils).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reduction in the number of platelets in the blood.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase of a substance in the blood called creatinine (produced by the body and removed by the kidney). These changes are usually mild in nature.</p><p>&nbsp;</p><p><strong>Common </strong>(may affect up to 1 in 10 people)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nose bleed &ndash; this is usually mild in nature.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hair thinning &ndash; this is usually mild in nature.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Itchy skin (pruritis) &ndash; Using moisturisers regularly on your skin can help with this.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hand-foot syndrome &ndash; this may include redness, swelling, tingling or burning sensation with cracking of the skin on the palms of hands and/or soles of feet. These types of effects can usually be treated with creams and lotions.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hives (urticaria) &ndash; itchy, raised patches anywhere on the skin, which may be pink or red and round in shape. Tell your doctor if you notice this side effect.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase of a substance in the blood called creatine phosphokinase (an enzyme released into the blood when muscle is damaged).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>&nbsp;</p><p>Store below 30&deg;C</p><p>&nbsp;</p><p>Do not use this medicine after the expiry date which is stated on the blister foil and carton after EXP. The expiry date refers to the last day of that month.</p><p>&nbsp;</p><p>This medicine does not require any special storage conditions.</p><p>&nbsp;</p><p>Do not use this medicine if the pack is damaged or shows signs of tampering.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The active substance is Osimertinib (as mesylate). Each 40&nbsp;mg film-coated tablet contains 40&nbsp;mg of Osimertinib. Each 80&nbsp;mg film-coated tablet contains 80&nbsp;mg of Osimertinib.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The other ingredients are mannitol, microcrystalline cellulose, low-substituted hydroxypropyl cellulose, sodium stearyl fumarate, polyvinyl alcohol, titanium dioxide, macrogol 3350, talc, yellow iron oxide, red iron oxide, black iron oxide (see section 2 &ldquo;TAGRISSO contains sodium&rdquo;).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                	TAGRISSO 40 mg is supplied as beige, film-coated, round and biconvex tablets, marked with “AZ” and “40” on one side, and plain on the other.
	
	TAGRISSO 80 mg is supplied as beige, film-coated, oval and biconvex tablets, marked with “AZ” and “80” on one side, and plain on the other.
	
	TAGRISSO is supplied in blisters containing 30 x 1 film-coated tablets, packed in cartons containing 3 blisters of 10 tablets each. 
	
	TAGRISSO is supplied in blisters containing 28 x 1 film-coated tablets, packed in cartons containing 4 blisters of 7 tablets each. 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorisation Holder</strong></p><p>AstraZeneca AB</p><p>SE‑151 85 S&ouml;dert&auml;lje</p><p>Sweden</p><p>&nbsp;</p><p><strong>Manufacturer</strong></p><p>AstraZeneca AB</p><p>G&auml;rtunav&auml;gen</p><p>SE‑151 85 S&ouml;dert&auml;lje</p><p>Sweden</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Oct 2024
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي عقار تاجريسو على المادة الفعالة أوزيميرتينيب، والتي تنتمي إلى مجموعة من الأدوية تسمى مثبطات بروتين كيناز والتي تستخدم لعلاج السرطان. يستخدم عقار تاجريسو لعلاج البالغين المصابين بنوع من سرطان الرئة يسمى &quot;سرطان الرئة ذو الخلايا غير الصغيرة&quot;. إذا أظهر الاختبار أن السرطان لديك به تغيرات معينة (طفرات) في جين يسمى &quot;EGFR&quot; (مستقبل عامل نمو البشرة)، فمن المرجح أن يستجيب السرطان لديك للعلاج باستخدام عقار تاجريسو.</p><p dir="RTL">يمكن وصف عقار تاجريسو لك بمفرده:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; للمساعدة في منع عودة سرطان الرئة بعد إزالة الورم (الأورام) لديك عن طريق الجراحة، أو</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عندما ينتشر سرطان الرئة إلى الأنسجة المجاورة (متقدم محليًا) ولا يمكن إزالته (غير قابل للاستئصال) عن طريق الجراحة واستجاب أو استقر بعد العلاج الكيميائي والعلاج الإشعاعي، أو</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كعلاج أول عندما ينتشر سرطان الرئة لديك إلى أجزاء أخرى من الجسم (نقيلي)، أو</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عندما ينتشر سرطان الرئة لديك إلى أجزاء أخرى من الجسم (نقيلي) وقد تلقيت علاجًا سابقًا بدواء مثبط تيروزين كيناز EGFR (TKI) الذي لم ينجح أو لم يعد يعمل.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">يمكن وصف تاجريسو لك، بالاشتراك مع أدوية أخرى مضادة للسرطان، بما في ذلك:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بالاشتراك مع بيميتريكسيد والعلاج الكيميائي القائم على البلاتين، كعلاجك الأول عندما ينتشر سرطان الرئة إلى الأنسجة المجاورة (متقدم محليًا) أو إلى أجزاء أخرى من الجسم (نقيلي).</p><p dir="RTL">عند إعطاء تاجريسو بالاشتراك مع أدوية أخرى مضادة للسرطان، من المهم أن تقرأ أيضًا النشرة الداخلية لهذه الأدوية الأخرى. إذا كانت لديك أي أسئلة حول هذه الأدوية، اسأل طبيبك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>طريقة عمل عقار تاجريسو</strong></p><p dir="RTL">يعمل تاجريسو عن طريق حجب مستقبلات عامل نمو البشرة (EGFR) وقد يساعد في إبطاء أو إيقاف نمو سرطان الرئة. وقد يساعد أيضًا في تقليل حجم الورم ومنع عودة الورم بعد إزالته بالجراحة.</p><p dir="RTL">&bull; إذا كنت تتلقى تاجريسو بعد إزالة السرطان بالكامل، فهذا يعني أن السرطان يحتوي على عيوب في جين مستقبلات عامل نمو البشرة (EGFR)، أو &quot;حذف الإكسون 19&quot; أو &quot;طفرة استبدال الإكسون 21&quot;.</p><p dir="RTL">&bull; إذا كان تاجريسو هو أول دواء مثبط للكيناز البروتيني تتلقاه، فهذا يعني أن السرطان يحتوي على عيوب في جين مستقبلات عامل نمو البشرة (EGFR)، على سبيل المثال &quot;حذف الإكسون 19&quot; أو &quot;طفرة استبدال الإكسون 21&quot;.</p><p dir="RTL">&bull; إذا تطور السرطان أثناء علاجك بأدوية مثبطة للكيناز البروتيني الأخرى، فهذا يعني أن السرطان يحتوي على عيب في الجين يسمى &quot;T790M&quot;. وبسبب هذا العيب، قد لا تعمل أدوية الكيناز البروتيني الأخرى.</p><p dir="RTL">إذا كان لديك أي أسئلة حول كيفية عمل هذا الدواء أو سبب وصف هذا الدواء لك، اسأل طبيبك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تتناول تاجريسو إذا</strong><strong>:</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حساسية (فرط الحساسية) تجاه أوسيميرتينيب أو أي من المكونات الأخرى لهذا الدواء (المذكورة في القسم 6).</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا لم تكن متأكدًا، تحدث إلى طبيبك أو الصيدلاني أو الممرضة قبل تناول تاجريسو.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>&nbsp;تحذيرات واحتياطات</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">تحدث إلى طبيبك أو الصيدلاني أو الممرضة قبل تناول دواء تاجريسو إذا:</p><p dir="RTL">&nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من التهاب في الرئتين (حالة تسمى &quot;مرض الرئة الخلالي&quot;).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من مشاكل في القلب من قبل - قد يرغب طبيبك في مراقبتك عن كثب.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لديك تاريخ من مشاكل العين.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لديك مشاكل في الجلد.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لديك التهاب في الأوعية الدموية في الجلد.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لديك مشاكل في الدم ونخاع العظام.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كان أي مما سبق ينطبق عليك (أو إذا لم تكن متأكدًا)، فتحدث إلى طبيبك أو الصيدلاني أو الممرضة قبل تناول هذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أخبر طبيبك مباشرةً أثناء تناول هذا الدواء في الحالات التالية</strong><strong>:</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لديك صعوبة مفاجئة في التنفس مع سعال أو حمى.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لديك بشرة شاحبة بشكل غير عادي.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لديك عيون دامعة، وحساسية للضوء، وألم في العين، واحمرار في العين أو تغيرات في الرؤية. راجع &quot;الآثار الجانبية الخطيرة&quot; في القسم 4 لمزيد من المعلومات.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لديك حمى مستمرة، وكدمات أو نزيف بسهولة، وزيادة التعب، وشحوب الجلد والعدوى. راجع &quot;الآثار الجانبية الخطيرة&quot; في القسم 4 لمزيد من المعلومات.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأطفال والمراهقون</strong></p><p dir="RTL">لم تتم دراسة تاجريسو لدى الأطفال أو المراهقين. لذا تجنب إعطاء هذا الدواء للأطفال أو المراهقين ممن يقل عمرهم</p><p dir="RTL">عن 18 عامًا .</p><p dir="RTL"><strong>الأدوية الأخرى و تاجريسو</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">أخبر طبيبك أو الصيدلاني إذا كنت تتناول أو تناولت مؤخرًا أو قد تتناول أي أدوية أخرى. وهذا يشمل الأدوية العشبية والأدوية التي يتم الحصول عليها بدون وصفة طبية. وذلك لأن تاجريسو يمكن أن يؤثر على طريقة عمل بعض الأدوية الأخرى. كما يمكن لبعض الأدوية الأخرى أن تؤثر على طريقة عمل تاجريسو.</p><p dir="RTL">&nbsp;</p><p dir="RTL">أخبر طبيبك قبل تناول تاجريسو إذا كنت تتناول أيًا من الأدوية التالية:</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد تقلل الأدوية التالية من فعالية تاجريسو:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الفينيتوين أو الكاربامازيبين أو الفينوباربيتال - تستخدم لعلاج النوبات أو النوبات.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ريفابوتين أو ريفامبيسين - تستخدم لعلاج مرض السل.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يؤثر تاجريسو على فعالية الأدوية التالية و/أو يزيد من الآثار الجانبية لهذه الأدوية:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; روزوفاستاتين - يستخدم لخفض الكوليسترول.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حبوب منع الحمل الهرمونية عن طريق الفم - تستخدم لمنع الحمل.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بوسنتان - يستخدم لعلاج ارتفاع ضغط الدم في الرئتين.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إيفافيرينز وإيترافيرين &ndash; يستخدمان لعلاج عدوى فيروس نقص المناعة البشرية/الإيدز.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مودافينيل &ndash; يستخدم لعلاج اضطرابات النوم.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; دابيغاتران &ndash; يستخدم لمنع تجلط الدم.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ديجوكسين &ndash; يستخدم لعلاج عدم انتظام ضربات القلب أو مشاكل القلب الأخرى.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أليسكيرين &ndash; يستخدم لعلاج ارتفاع ضغط الدم.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كنت تتناول أيًا من الأدوية المذكورة أعلاه، أخبر طبيبك قبل تناول تاجريسو. سيناقش طبيبك خيارات العلاج المناسبة معك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل &ndash; معلومات للنساء</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حامل أو تخططين للحمل. يمكن أن يضر تاجريسو بجنينك. أخبري مقدم الرعاية الصحية الخاص بك على الفور إذا أصبحت حاملاً أثناء العلاج بتاجريسو أو تعتقدين أنك قد تكونين حاملاً</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب على النساء القادرات على الحمل إجراء اختبار حمل قبل بدء العلاج بتاجريسو. يجب عليك استخدام وسائل منع الحمل الفعالة أثناء العلاج بـ تاجريسو ولمدة 6 أسابيع بعد الجرعة الأخيرة من تاجريسو</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل - معلومات للرجال</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يجب على من لديهم شريكات قادرات على الحمل استخدام وسائل منع الحمل الفعالة أثناء العلاج بـ تاجريسو ولمدة 4 أشهر بعد الجرعة الأخيرة من تاجريسو</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>منع الحمل - معلومات للنساء والرجال</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب عليك استخدام وسائل منع الحمل الفعالة أثناء العلاج.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يتداخل تاجريسو مع مدى فعالية وسائل منع الحمل الهرمونية الفموية. ناقش مع طبيبك أكثر طرق منع الحمل ملاءمة.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد ينتقل تاجريسو إلى السائل المنوي. لذلك، من المهم أن يستخدم الرجال أيضًا وسائل منع الحمل الفعالة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب عليك أيضًا القيام بذلك بعد الانتهاء من العلاج بـ تاجريسو:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النساء - استمري في استخدام وسائل منع الحمل لمدة شهرين بعد ذلك.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الرجال - استمري في استخدام وسائل منع الحمل لمدة 4 أشهر بعد ذلك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الرضاعة الطبيعية</strong></p><p dir="RTL">لا ترضعي طفلك رضاعة طبيعية أثناء تناول هذا الدواء. هذا لأنه من غير المعروف ما إذا كان هناك خطر على طفلك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">لا يوجد لدواء تاجريسو أي تأثير ملحوظ على القدرة على القيادة واستخدام الآلات.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>يحتوي دواء تاجريسو على الصوديوم</strong></p><p dir="RTL">يحتوي هذا الدواء على أقل من 1 مليمول صوديوم (23 مجم) لكل قرص، أي أنه &quot;خالي من الصوديوم&quot; بشكل أساسي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تناول هذا الدواء دائمًا كما أخبرك طبيبك أو الصيدلاني. استشر طبيبك أو الصيدلاني إذا لم تكن متأكدًا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">الجرعة التي يجب تناولها</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تناول تاجريسو تمامًا كما أخبرك مقدم الرعاية الصحية الخاص بك.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد يغير مقدم الرعاية الصحية جرعتك أو يوقف العلاج بـ تاجريسو مؤقتًا أو بشكل دائم إذا ظهرت عليك آثار جانبية.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تناول تاجريسو مرة واحدة كل يوم.</p><p dir="RTL">&nbsp;</p><p dir="RTL">كيفية تناول الدواء</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يتم تناول تاجريسو عن طريق الفم. ابتلع القرص كاملاً مع الماء. لا تسحق القرص أو تقسمه أو تمضغه.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تناول تاجريسو كل يوم في نفس الوقت.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يمكنك تناول هذا الدواء مع أو بدون طعام.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا واجهت صعوبة في بلع القرص، يمكنك مزجه في الماء:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضع جرعتك من تاجريسو في وعاء يحتوي على 60 مل (2 أونصة) من الماء. لا تستخدم الماء الفوار أو أي سوائل أخرى.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حرك قرص تاجريسو والماء حتى يتحول قرص تاجريسو إلى قطع صغيرة (لن يذوب القرص تمامًا). لا تسحقه أو تسخنه أو تستخدم الموجات فوق الصوتية لتحضير الخليط.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اشرب خليط تاجريسو والماء على الفور.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أضف 120 مل إلى 240 مل (4 إلى 8 أونصات) من الماء في الحاوية واشرب للتأكد من تناول الجرعة الكاملة من تاجريسو.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا كان لديك أنبوب أنفي معدي (</strong><strong>NG</strong><strong>):</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اتبع نفس التعليمات لخلط أقراص تاجريسو في حاوية تحتوي على 15 مل من الماء. لا تستخدم الماء الفوار أو أي سوائل أخرى.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حرك أقراص تاجريسو والماء حتى تتحول أقراص تاجريسو إلى قطع صغيرة (لن تذوب الأقراص تمامًا). لا تسحقه أو تسخنه أو تستخدم الموجات فوق الصوتية لتحضير الخليط.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أضف 15 مل أخرى من الماء في الحاوية للتأكد من عدم بقاء أي قطع من قرص تاجريسو.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أعطِ قرص تاجريسو وخليط الماء باستخدام تعليمات الشركة المصنعة لأنبوب NG في غضون 30 دقيقة.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أضف 30 مل أخرى من الماء إلى المحقنة وأعطِ الماء وأي تاجريسو متبقي من خلال أنبوب NG للتأكد من إعطاء الدواء بالكامل. كرر هذه الخطوة حتى لا تبقى أي قطع في المحقنة. سيساعد هذا في ضمان إعطاء الجرعة الموصوفة بالكامل من تاجريسو.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا تناولت تاجريسو أكثر مما ينبغي</strong></p><p dir="RTL">إذا تناولت أكثر من جرعتك العادية، اتصل بطبيبك أو أقرب مستشفى على الفور.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا نسيت تناول تاجريسو</strong></p><p dir="RTL">إذا نسيت تناول جرعة من تاجريسو ، فلا تعوض الجرعة الفائتة. تناول الجرعة التالية في وقتك المعتاد.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا توقفت عن تناول تاجريسو</strong></p><p dir="RTL">لا تتوقف عن تناول هذا الدواء - تحدث إلى طبيبك أولاً. من المهم تناول هذا الدواء كل يوم، طالما وصفه لك طبيبك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كان لديك أي أسئلة أخرى حول استخدام هذا الدواء، اسأل طبيبك أو الصيدلي أو الممرضة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، يمكن أن يسبب هذا الدواء آثارًا جانبية، على الرغم من أن هذه الآثار لا تصيب الجميع.</p><p dir="RTL">&nbsp;</p><p dir="RTL">آثار جانبية خطيرة</p><p dir="RTL">أخبر طبيبك على الفور إذا لاحظت أيًا من الآثار الجانبية الخطيرة التالية (انظر أيضًا القسم 2):</p><p dir="RTL">&nbsp;</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>مشاكل في الرئة</strong>. قد يسبب تاجريسو مشاكل في الرئة قد تؤدي إلى الوفاة. قد تكون الأعراض مشابهة لتلك الأعراض التي تظهر في سرطان الرئة. أخبر مقدم الرعاية الصحية الخاص بك على الفور إذا كان لديك أي أعراض رئوية جديدة أو متفاقمة، بما في ذلك صعوبة التنفس، وضيق التنفس، والسعال، أو الحمى.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>مشاكل في القلب</strong>، بما في ذلك قصور القلب. قد يسبب تاجريسو مشاكل في القلب قد تؤدي إلى الوفاة. يجب على مقدم الرعاية الصحية الخاص بك فحص وظائف القلب قبل البدء في تناول تاجريسو وأثناء العلاج حسب الحاجة. أخبر مقدم الرعاية الصحية الخاص بك على الفور إذا كان لديك أي من العلامات والأعراض التالية لمشكلة في القلب: الشعور بأن قلبك ينبض أو يتسابق، وضيق في التنفس، وتورم الكاحلين والقدمين، والدوخة، والشعور بالدوار، أو الشعور بالإغماء.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>مشاكل في العين</strong>. قد يسبب تاجريسو مشاكل في العين. أخبر مقدم الرعاية الصحية الخاص بك على الفور إذا كنت تعاني من أعراض مشاكل في العين والتي قد تشمل عيون دامعة، حساسية للضوء، ألم في العين، احمرار العين، أو تغيرات في الرؤية. قد يرسلك مقدم الرعاية الصحية الخاص بك إلى طبيب عيون (طبيب عيون) إذا كنت تعاني من مشاكل في العين بسبب تاجريسو.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>مشاكل الجلد</strong>. قد يسبب تاجريسو مشاكل في الجلد. أخبر مقدم الرعاية الصحية الخاص بك على الفور إذا ظهرت عليك ردود فعل جلدية تشبه الحلقات (آفات مستهدفة)، أو ظهور بثور شديدة أو تقشير في الجلد.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>التهاب الأوعية الدموية في الجلد</strong>. قد يسبب تاجريسو مشاكل في الأوعية الدموية في الجلد. أخبر مقدم الرعاية الصحية الخاص بك على الفور إذا ظهرت عليك بقع أرجوانية أو احمرار في الجلد لا يتلاشى لونه عند الضغط عليه (غير ابيضاض) على الجزء السفلي من الذراعين أو الساقين أو الأرداف أو شرى كبير على الجزء الرئيسي من الجسم (الجذع) لا يختفي في غضون 24 ساعة ويبدو وكأنه كدمة.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>مشاكل في الدم ونخاع العظم</strong>. قد يسبب تاجريسو حالة حيث لا يستطيع نخاع العظم إنتاج ما يكفي من خلايا الدم الجديدة (فقر الدم اللاتنسجي)، وقد يؤدي ذلك إلى الوفاة. سيراقب مقدم الرعاية الصحية الخاص بك عدد خلايا الدم لديك قبل البدء وأثناء العلاج بـ تاجريسو. أخبر مقدم الرعاية الصحية الخاص بك على الفور إذا ظهرت عليك أي علامات أو أعراض تشير إلى مشاكل في الدم ونخاع العظم، بما في ذلك:</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تعب</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضعف</p></td><td style="vertical-align:top"><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سهولة ظهور كدمات أو نزيف لا يتوقف</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بشرة شاحبة بشكل غير عادي</p></td><td style="vertical-align:top"><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حمى جديدة أو حمى لا تزول (درجة الحرارة 100.4 درجة فهرنهايت أو أعلى)</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الآثار الجانبية الأخرى</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>شائعة جدًا (قد تؤثر على أكثر من 1 من كل 10 أشخاص)</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإسهال - قد يأتي ويذهب أثناء العلاج. أخبر طبيبك إذا لم يختفي الإسهال أو أصبح شديدًا.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل الجلد والأظافر - قد تشمل العلامات الألم والحكة وجفاف الجلد والطفح الجلدي والاحمرار حول الأظافر. هذا هو أكثر احتمالا في المناطق المعرضة للشمس. يمكن أن يساعد استخدام المرطبات بانتظام على بشرتك وأظافرك في هذا. أخبر طبيبك إذا تفاقمت مشاكل الجلد أو الأظافر.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الفم - التهاب بطانة الفم الداخلية أو تقرحات تتشكل في الفم.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الشهية.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض في عدد خلايا الدم البيضاء (الكريات البيضاء أو الخلايا الليمفاوية أو العدلات).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض في عدد الصفائح الدموية في الدم.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>شائعة (قد تؤثر على ما يصل إلى 1 من كل 10 أشخاص)</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نزيف الأنف (رعاف).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ترقق الشعر (الثعلبة).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشرى (الشرى) - بقع مرتفعة مثيرة للحكة في أي مكان على الجلد، وقد تكون وردية أو حمراء ومستديرة الشكل. أخبر طبيبك إذا لاحظت هذا التأثير الجانبي.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; متلازمة اليد والقدم - قد تشمل احمرارًا أو تورمًا أو وخزًا أو إحساسًا بالحرق مع تشقق الجلد في راحة اليدين و/أو باطن القدمين.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة مادة في الدم تسمى الكرياتينين (ينتجها الجسم وتزيلها الكلى).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة مادة في الدم تسمى فوسفوكيناز الكرياتين (إنزيم يفرز في الدم عند تلف العضلات).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>غير شائع (قد يؤثر على ما يصل إلى 1 من كل 100 شخص)</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آفات مستهدفة، وهي تفاعلات جلدية تبدو مثل الحلقات (تشير إلى الحمامي المتعددة الأشكال).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الأوعية الدموية في الجلد. قد يعطي هذا مظهر كدمات أو احمرار الجلد الذي لا يتلاشى لونه عند الضغط عليه (غير ابيضاض).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>نادرًا (قد يؤثر على ما يصل إلى 1 من كل 1000 شخص)</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب العضلات الذي قد يؤدي إلى آلام العضلات أو ضعفها</p><p dir="RTL">&nbsp;</p><p dir="RTL">الآثار الجانبية التالية لـ تاجريسو بالاشتراك مع بيميتريكسيد والعلاج الكيميائي القائم على البلاتين تشمل:</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>شائع جدًا (قد يؤثر على أكثر من 1 من كل 10 أشخاص)</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإسهال - قد يأتي ويختفي أثناء العلاج. أخبر طبيبك إذا لم يختفي الإسهال أو أصبح شديدًا.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل الجلد والأظافر - قد تشمل العلامات الحكة وجفاف الجلد والطفح الجلدي والاحمرار حول الأظافر. يمكن أن يساعد استخدام المرطبات بانتظام على بشرتك وأظافرك في هذا. أخبر طبيبك إذا تفاقمت مشاكل الجلد أو الأظافر.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الفم - التهاب بطانة الفم الداخلية أو تقرحات تتشكل في الفم.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض في عدد خلايا الدم البيضاء (الكريات البيضاء أو الخلايا الليمفاوية أو العدلات).</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض في عدد الصفائح الدموية في الدم.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة مادة في الدم تسمى الكرياتينين (ينتجها الجسم وتتخلص منها الكلى). هذه التغيرات عادة ما تكون خفيفة بطبيعتها.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>شائعة (قد تؤثر على ما يصل إلى 1 من كل 10 أشخاص)</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نزيف الأنف - عادة ما يكون خفيفًا بطبيعته.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ترقق الشعر - عادة ما يكون خفيفًا بطبيعته.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حكة الجلد (الحكة) - يمكن أن يساعد استخدام المرطبات بانتظام على بشرتك في هذا.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; متلازمة اليد والقدم - قد تشمل احمرارًا أو تورمًا أو وخزًا أو حرقًا مع تشقق الجلد في راحة اليدين و/أو باطن القدمين. يمكن علاج هذه الأنواع من التأثيرات عادةً بالكريمات والمستحضرات.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشرى - بقع حكة مرتفعة في أي مكان على الجلد، وقد تكون وردية أو حمراء ومستديرة الشكل. أخبر طبيبك إذا لاحظت هذا التأثير الجانبي.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة مادة في الدم تسمى فوسفوكيناز الكرياتين (إنزيم يتم إطلاقه في الدم عند تلف العضلات).</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احفظ هذا الدواء بعيدًا عن متناول الأطفال.</p><p dir="RTL">يُخزن في درجة حرارة أقل من 30 درجة مئوية</p><p dir="RTL">لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية الموضح على ورق الفقاعة والعلبة بعد EXP. يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">لا يتطلب هذا الدواء أي ظروف تخزين خاصة.</p><p dir="RTL">لا تستخدم هذا الدواء إذا كانت العبوة تالفة أو تظهر عليها علامات العبث.</p><p dir="RTL">لا تتخلص من أي أدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد تستخدمها. ستساعد هذه التدابير في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المادة الفعالة هي أوزيميرتينيب (في شكل ميسيلات).</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحتوي كل قرص مغلف 40 ملغ على 40 ملغ من أوزيميرتينيب.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحتوي كل قرص مغلف 80 ملغ على 80 ملغ من أوزيميرتينيب.</p><p dir="RTL">&nbsp;</p><p dir="RTL">المكونات الأخرى هي المانيتول ، السليلوز الجريزوفولفين ، هيدروكسي بروبيل السليلوز منخفض الاستبدال ، الصوديوم ستيريل فوماريت ، كحول البولي فينيل ، ثاني أكسيد التيتانيوم ، ماكروغول 3350 ، التلك ، أكسيد الحديد الأصفر ، أكسيد الحديد الأحمر ، أكسيد الحديد الأسود (انظر القسم 2 &quot;تحتوي تاغريسسو على الصوديوم &quot;).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يأتي تاجريسو 40 ملغ في شكل أقراص مغلفة مستديرة وثنائية التحدب لونها بيج، مميزة بحرفي &quot; AZ &quot; و&quot; 40 &quot; على</p><p dir="RTL">أحد الجانبين وبدون أيّ طباعة على الجانب الآخر.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يأتي تاجريسو 80 ملغ على شكل أقراص مغلفة بيضاوية وثنائية التحدب لونها بيج مميزة بحرفي &quot; AZ &quot; و&quot; 80 &quot;</p><p dir="RTL">على أحد الجانبين وبدون أيّ طباعة على الجانب الآخر .</p><p dir="RTL">&nbsp;</p><p dir="RTL">يأتي عقار تاجريسو في أشرطة تحتوي على 30 قرصًا مغلفًا ومعبأ في علب كرتونية تحتوي على 3 أشرطة يحتوي</p><p dir="RTL">كل منها على 10 أقراص.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يأتي عقار تاجريسو في أشرطة تحتوي على 28 قرصًا مغلفًا ومعبأ في علب كرتونية تحتوي على 4 أشرطة يحتوي</p><p dir="RTL">كل منها على 7 أقراص .</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">AstraZeneca AB</p><p dir="RTL">SE-151 85 S&ouml;dert&auml;lje ،</p><p dir="RTL">السويد</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>والشركة المصنعة</strong></p><p dir="RTL">AstraZeneca AB</p><p dir="RTL">SE-151 85 S&ouml;dert&auml;lje ،</p><p dir="RTL">السويد</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            اكتوبر  2024
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                TAGRISSO 40 mg film-coated tablets
TAGRISSO 80 mg film-coated tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                TAGRISSO 40 mg tablets
Each tablet contains 40 mg osimertinib (as mesylate). TAGRISSO 80 mg tablets
Each tablet contains 80 mg osimertinib (as mesylate). Excipient with known effect
TAGRISSO 40 mg tablets
Each tablet contains 0.3 mg sodium.

TAGRISSO 80 mg tablets
Each tablet contains 0.6 mg sodium.
For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablet (tablet). TAGRISSO 40 mg tablets
Beige, 9 mm, round, biconvex tablet, debossed with “AZ” and “40” on one side and plain on the reverse. TAGRISSO 80 mg tablets
Beige, 7.25 x 14.5 mm, oval, biconvex tablet, debossed with “AZ” and “80” on one side and plain on the reverse.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>TAGRISSO as monotherapy is indicated for:</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the adjuvant treatment after complete tumor resection in adult patients non- small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) substitution mutations (see section 5.1).</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the first-line treatment of adult patients with locally advanced or metastatic NSCLC whose tumors have EGFR exon 19 deletions or exon 21 L858R mutations.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the treatment of adult patients with metastatic EGFR T790M mutation-positive NSCLC whose disease has progressed on or after EGFR tyrosine kinase inhibitor (TKI) therapy.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TAGRISSO is indicated for the treatment of adult patients with locally advanced, unresectable (stage III) NSCLC whose disease has not progressed during or following concurrent or sequential platinum-based chemoradiation therapy and whose tumors have EGFR exon&nbsp;19&nbsp;deletions or exon&nbsp;21&nbsp;L858R mutations.</p><p>&nbsp;</p><p>TAGRISSO is indicated in combination with:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TAGRISSO in combination with pemetrexed and platinum-based chemotherapy is indicated for the first-line treatment of adult patients with locally advanced or metastatic NSCLC whose tumours have EGFR exon 19 deletions or exon 21 L858R mutations.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Treatment with TAGRISSO should be initiated by a physician experienced in the use of anticancer therapies.</p><p>When considering the use of TAGRISSO, EGFR mutation status (in tumour specimens for adjuvant treatment and tumor or plasma specimens for locally advanced or metastatic setting) should be determined using a validated test method (see section 4.4).</p><p>&nbsp;</p><p><u>Posology</u></p><p><em>Monotherapy</em></p><p><em>&nbsp;</em></p><p>The recommended dose is 80 mg Osimertinib once a day.</p><p>&nbsp;</p><p><em>Combination therapy</em></p><p><em>&nbsp;</em></p><p>The recommended dose of TAGRISSO is 80 mg Osimertinib once a day when taken with pemetrexed and platinum-based chemotherapy.</p><p>Refer to the Summary of Product Characteristics for pemetrexed and cisplatin or carboplatin for the respective dosing information.</p><p>Patients in the adjuvant setting should receive treatment until disease recurrence or unacceptable toxicity. Treatment duration for more than 3 years was not studied.</p><p>Patients with locally advanced or metastatic lung cancer should receive TAGRISSO treatment until disease progression or unacceptable toxicity.</p><p>If a dose of TAGRISSO is missed, do not make up the missed dose and take the next dose as scheduled.</p><p>TAGRISSO can be taken with or without food at the same time each day, Tablets may be dispersed in water for patients who have difficulty swallowing, or for nasogastric tube administration.</p><p><em><u>Dose adjustments.</u></em></p><p>Dosing interruption and/or dose reduction may be required based on individual safety and tolerability. If dose reduction is necessary, then the dose should be reduced to 40 mg taken once daily.</p><p>&nbsp;</p><p>Dose reduction guidelines for adverse reactions toxicities are provided in Table 1.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Table 1. Recommended dose modifications for TAGRISSO<!--[if supportFields]><span
style='letter-spacing:-.1pt'><span style='mso-element:field-begin'></span>
DOCVARIABLE vault_nd_576f0fb5-57ef-4ff2-b501-26a2e42f1e51 \* MERGEFORMAT <span
style='mso-element:field-separator'></span></span><![endif]-->&nbsp;<!--[if supportFields]><span
style='letter-spacing:-.1pt'><span style='mso-element:field-end'></span></span><![endif]--></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Target organ</strong></p></td><td style="vertical-align:top"><p><strong>Adverse reaction</strong><sup>a</sup></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p><p><strong>Dose modification</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Pulmonary<sup>b</sup></em></p><p><em>(Patients who have <strong><u>not</u></strong> received recent definitive platinum-based chemoradiation therapy)</em></p></td><td style="vertical-align:top"><p>Any Grade</p><p>Interstitial lung disease</p><p>ILD/Pneumonitis</p></td><td style="vertical-align:top"><p>Permanently discontinue TAGRISSO</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Pulmonary</p><p><em>(Patients who <strong><u>have </u></strong>received recent definitive platinum-based chemoradiation therapy)</em></p></td><td style="vertical-align:top"><p>Grade 1</p><p>ILD/Pneumonitis</p></td><td style="vertical-align:top"><p>Withhold or continue TAGRISSO, as clinically indicated.</p></td></tr><tr><td style="vertical-align:top"><p>Grade &ge;2</p><p>ILD/Pneumonitis</p></td><td style="vertical-align:top"><p>Permanently discontinue TAGRISSO.&nbsp;&nbsp;</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p><em>Cardiac<sup>b</sup></em></p></td><td style="vertical-align:top"><p>QTc interval greater than 500 msec on at least 2 separate ECGs</p></td><td style="vertical-align:top"><p>Withhold TAGRISSO until QTc interval is less than 481 msec or recovery to baseline if baseline QTc is greater than or equal to</p><p>481 msec, then restart at a reduced dose (40 mg)</p></td></tr><tr><td style="vertical-align:top"><p>QTc interval prolongation with signs/symptoms of life-threatening arrhythmia</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Permanently discontinue TAGRISSO</p></td></tr><tr><td style="vertical-align:top"><p>Symptomatic congestive heart failure</p></td><td style="vertical-align:top"><p>Permanently discontinue TAGRISSO</p></td></tr><tr><td style="vertical-align:top"><p><em>Cutaneous<sup>b</sup></em></p></td><td style="vertical-align:top"><p>Erythema Multiforme Major (EMM), Stevens-Johnson Syndrome and Toxic epidermal necrolysis (TEN)</p></td><td style="vertical-align:top"><p>Permanently discontinue TAGRISSO</p></td></tr><tr><td style="vertical-align:top"><p><em>Blood and</em></p><p><em>lymphatic system<sup>b</sup></em></p></td><td style="vertical-align:top"><p>Aplastic anaemia</p></td><td style="vertical-align:top"><p>Withhold TAGRISSO if aplastic anemia is suspected and permanently discontinue if confirmed.</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p><em>Other</em></p></td><td style="vertical-align:top"><p>Adverse reaction of Grade 3 or greater severity</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Withhold TAGRISSO for up to 3 weeks</p></td></tr><tr><td style="vertical-align:top"><p>If improvement to Grade 0-2 within 3&nbsp;weeks</p><p>&nbsp;</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Resume at 80&nbsp;mg or 40&nbsp;mg daily.</p><p>&nbsp;</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>If no improvement within 3 weeks</p><p>&nbsp;</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Permanently discontinue TAGRISSO</p></td></tr></tbody></table><p>a&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Note: The intensity of clinical adverse events graded by the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version 4.0.</p><p>b&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Refer to section 4.4.</p><p>ECGs: Electrocardiograms; QTc: QT interval corrected for heart rate.</p><p>&nbsp;</p><p><strong><em>Combination therapy</em></strong></p><p><em>&nbsp;</em></p><p>When TAGRISSO is administered in combination with pemetrexed and platinum-based chemotherapy, modify the dose of any one of the treatments for the management of adverse reactions, as appropriate. For TAGRISSO dose modification instructions, see Table 2. Withhold, reduce the dose or permanently discontinue pemetrexed, cisplatin or carboplatin according to their respective Prescribing Information.</p><p>&nbsp;</p><p><em><u>Special populations</u></em></p><p>No dose adjustment is required due to patient age, body weight, gender, ethnicity and smoking status (see section 5.2).</p><p><em><u>Hepatic impairment</u></em></p><p><em>&nbsp;</em></p><p>No dose adjustment is recommended in patients with mild to moderate hepatic impairment (Child-Pugh A and B or total bilirubin &le; ULN and AST &gt; ULN or total bilirubin 1 to 3 times ULN and any AST).<em> </em>There is no recommended dose for TAGRISSO for patients with severe hepatic impairment</p><p>(see section 5.2).</p><p>&nbsp;</p><p><em><u>Renal impairment</u></em></p><p><em>&nbsp;</em></p><p>No dose adjustment is recommended in patients with creatinine clearance (CLcr) 15 - 89&nbsp;mL/min, as estimated by Cockcroft-Gault. There is no recommended dose of TAGRISSO for patients with end-stage renal disease (CLcr &lt;15&nbsp;mL/min)<em> </em></p><p>&nbsp;(see section 5.2).</p><p><em><u>Paediatric population</u></em></p><p>The safety and effectiveness of TAGRISSO in pediatric patients have not been established</p><p>Geriatric <em><u>population</u></em></p><p>TAGRISSO Following Definitive Platinum-based Chemoradiation Therapy</p><p>Of the 142 patients with EGFR exon 19 deletion or exon 21 L858R mutation-positive, locally advanced unresectable (Stage III) NSCLC treated with TAGRISSO following definitive platinum-based chemoradiation therapy, 62 patients were &ge;65 years and 13 patients were &ge;75 years of age. No overall differences in safety or effectiveness were observed between patients 65 years or older and younger patients.</p><p><u>Method of administration</u></p><p>&nbsp;</p><p>Administer TAGRISSO 80&nbsp;mg tablet orally once daily with or without food. Tablets may be dispersed in water for patients who have difficulty swallowing, or for nasogastric tube administration</p><p>&nbsp;</p><p>If the patient is unable to swallow the tablet, Disperse tablet in 60 mL (2 ounces) of non-carbonated water only. Stir until tablet is dispersed into small pieces (the tablet will not completely dissolve) and swallow immediately. Do not crush, heat, or ultrasonicate during preparation. Rinse the container with 120 mL to 240 mL (4 to 8 ounces) of water and immediately drink.</p><p>If administration via nasogastric tube is required, disperse the tablet as above in 15 mL of non-carbonated water, and then use an additional 15 mL of water to transfer any residues to the syringe. The resulting 30 mL liquid should be administered as per the nasogastric tube instructions with appropriate water flushes (approximately 30 mL). Repeat this step until no pieces remain in the syringe. This will help to ensure that the full prescribed dose of the TAGRISSO is given.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                None
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Assessment of EGFR mutation status</u></p><p>When considering the use of TAGRISSO as adjuvant treatment after complete tumour resection in patients with NSCLC, it is important that the EGFR mutation positive status (exon 19 deletions (Ex19del) or exon 21 L858R substitution mutations (L858R)) indicates treatment eligibility. A validated test should be performed in a clinical laboratory using tumour tissue DNA from biopsy or surgical specimen.</p><p>When considering the use of TAGRISSO as a treatment for locally advanced or metastatic NSCLC, it is important that the EGFR mutation positive status is determined. A validated test should be performed using either tumour DNA derived from a tissue sample or circulating tumour DNA (ctDNA) obtained from a plasma sample.</p><p>&nbsp;</p><p>Positive determination of EGFR mutation status (activating EGFR mutations for first-line treatment, exon 19 deletion or exon 21 (L858R) substitution mutations when TAGRISSO is given in combination</p><p>with pemetrexed and platinum-based chemotherapy for first-line treatment or T790M mutations following progression on or after EGFR TKI therapy) using either a tissue-based or plasma-based test indicates eligibility for treatment with TAGRISSO. However, if a plasma-based ctDNA test is used and the result is negative, it is advisable to follow-up with a tissue test wherever possible due to the potential for false negative results using a plasma-based test.</p><p>&nbsp;</p><p>Only robust, reliable and sensitive tests with demonstrated utility for the determination of EGFR mutation status should be used.</p><p><strong><u>Interstitial Lung Disease (ILD)</u></strong></p><p>TAGRISSO can cause severe and fatal ILD/pneumonitis.</p><p>&nbsp;</p><p>Across clinical trials, interstitial lung disease (ILD)/pneumonitis occurred in 4% of the 1813patients treated with TAGRISSO monotherapy who had not received recent definitive chemoradiation therapy; 0.4% of cases were fatal .</p><p><em>ILD/Pneumonitis with TAGRISSO in Combination with Pemetrexed and Platinum-based Chemotherapy</em></p><p>&nbsp;</p><p>In the FLAURA2 study, ILD/pneumonitis occurred in 3.3% of the 276 patients who received TAGRISSO in combination with pemetrexed and platinum-based chemotherapy; 0.4% of cases were fatal.</p><p>&nbsp;</p><p><em>ILD/Pneumonitis Following Definitive Platinum-based Chemoradiation Therapy</em></p><p>&nbsp;</p><p>In the LAURA study, following definitive platinum-based chemoradiation therapy, ILD/pneumonitis, including radiation pneumonitis, occurred in 80 of the 143 patients (56%) who received TAGRISSO monotherapy and 28 of the 73 patients (38%) who received placebo. There was one fatal case (0.7%), 3.5% Grade 3, 34% Grade 2, and 18% Grade 1 adverse reactions of ILD/pneumonitis in TAGRISSO-treated patients. For TAGRISSO-treated patients, ILD/pneumonitis led to permanent discontinuation of TAGRISSO in 7% of patients and dosage interruptions of TAGRISSO in 35% of patients. Among the 46 patients who were rechallenged with TAGRISSO, 11% had recurrence of ILD/pneumonitis. In the 80 TAGRISSO-treated patients, ILD/pneumonitis resolved in 40%, resolved with sequelae in 1.3%, were resolving in 16%, did not resolve in 41%, and resulted in death in 1.3%.</p><p>&nbsp;</p><p>For patients receiving TAGRISSO who have not received recent definitive platinum-based chemoradiation therapy,withhold TAGRISSO and promptly investigate for ILD in patients who present with worsening of respiratory symptoms which may be indicative of ILD (e.g., dyspnea, cough and fever). Permanently discontinue TAGRISSO if ILD/pneumonitis is confirmed.</p><p>For patients who have received recent definitive platinum-based chemoradiation therapy with Grade 1 ILD/pneumonitis continue TAGRISSO or interrupt and restart, as appropriate. Permanently discontinue TAGRISSO in patients diagnosed with Grade &ge;2 ILD/pneumonitis</p><p>&nbsp;</p><p><strong><u>Severe Cutaneous Adverse Reactions (SCARs)</u></strong></p><p>Post marketing cases consistent with erythema multiforme major (EMM), Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) have been reported in patients receiving TAGRISSO. Withhold TAGRISSO if EMM, SJS, or TEN is suspected and permanently discontinue if confirmed.</p><p>&nbsp;</p><p><strong><u>QTc interval prolongation</u></strong></p><p>TAGRISSO can cause heart rate-corrected QT (QTc) interval prolongation .. Of the 1813 patients treated with TAGRISSO monotherapy in clinical trials, 1.1% were found to have a QTc &gt;500 msec, and 4.3% of patients had an increase from baseline QTc &gt;60.</p><p>Of the 276 patients treated with TAGRISSO in combination with pemetrexed and platinum-based chemotherapy in the FLAURA2 study, 1.8% were found to have a QTc &gt;500 msec, and 10.5% of patients had an increase from baseline QTc &gt;60 msec.</p><p><strong>No QTc-related arrhythmias were reported.</strong></p><p>Clinical trials of TAGRISSO did not enroll patients with baseline QTc of &gt;470 msec. Conduct periodic monitoring with ECGs and electrolytes in patients with congenital long QTc syndrome, congestive heart failure, electrolyte abnormalities, or those who are taking medications known to prolong the QTc interval. Permanently discontinue TAGRISSO in patients who develop QTc interval prolongation with signs/symptoms of life-threatening arrhythmia.</p><p>&nbsp;</p><p><strong>Cardiomyopathy </strong></p><p>TAGRISSO can cause cardiomyopathy, including cardiac failure, chronic cardiac failure, congestive heart failure, pulmonary edema or decreased ejection fraction.</p><p>Across clinical trials, cardiomyopathy (occurred in 3.8% of the 1813 TAGRISSO-treated patients; 0.1% of cardiomyopathy cases were fatal.</p><p>In the FLAURA2 study, cardiomyopathy occurred in 9% of the 276 patients who received TAGRISSO in combination with pemetrexed and platinum-based chemotherapy; 1.1% of cardiomyopathy cases were fatal.</p><p>A decline in left ventricular ejection fraction (LVEF) &ge;10 percentage points from baseline and to less than 50% LVEF occurred in 4.2% of 1557 patients who had baseline and at least one follow-up LVEF assessment. In the ADAURA study, 1.5% (5/325) of patients treated with TAGRISSO experienced LVEF decreases greater than or equal to 10 percentage points and a drop to less than 50%. In the LAURA study, following platinum‑based chemoradiation therapy, 3% (4/135) of patients treated with TAGRISSO and no patients treated with placebo experienced LVEF decreases greater than or equal to 10&nbsp;percentage points and a drop to less than 50%. In the FLAURA2 study, 8% (21/262) of patients treated with TAGRISSO in combination with pemetrexed and platinum-based chemotherapy, who had baseline and at least one follow-up LVEF assessment, experienced LVEF decreases greater than or equal to 10 percentage points and a drop to less than 50%.</p><p>For patients who will be receiving TAGRISSO monotherapy, conduct cardiac monitoring, including assessment of LVEF at baseline and during treatment, in patients with cardiac risk factors.</p><p>For patients who will be receiving TAGRISSO in combination with pemetrexed and platinum-based chemotherapy, conduct cardiac monitoring, including assessment of LVEF at baseline and during treatment, in all patients.</p><p>Assess LVEF in patients who develop relevant cardiac signs or symptoms during treatment. For symptomatic congestive heart failure, permanently discontinue TAGRISSO</p><p>&nbsp;</p><p><u>Keratitis</u></p><p>Keratitis was reported in 0.6% (n=10) of the 1813 patients treated with TAGRISSO monotherapy in the Clinical Studies. Patients presenting with signs and symptoms suggestive of keratitis such as acute or worsening: eye inflammation, lacrimation, light sensitivity, blurred vision, eye pain and/or red eye should be referred promptly to an ophthalmology specialist (see section 4.2 Table 1).</p><p><u>Aplastic Anemia</u></p><p>&nbsp;</p><p>Aplastic anemia has been reported in patients treated with TAGRISSO in clinical trials (0.06% of 1813) and post marketing. Some cases had a fatal outcome. Inform patients of the signs and symptoms of aplastic anemia including but not limited to, new or persistent fevers, bruising, bleeding, and pallor. If aplastic anemia is suspected, withhold TAGRISSO and obtain a hematology consultation. If aplastic anemia is confirmed, permanently discontinue TAGRISSO (see section 4.2).</p><p>&nbsp;</p><p><u>Sodium</u></p><p>This medicinal product contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially &ldquo;sodium-free&rdquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pharmacokinetic interactions</u></p><p>&nbsp;</p><p>Effect of Other Drugs on TAGRISSO in Clinical Pharmacokinetic Studies Strong CYP3A Inducers: The steady-state AUC of osimertinib was reduced by 78% in patients when co-administered with rifampin (600 mg daily for 21 days) [see Drug Interactions (7.1)].</p><p>Strong CYP3A Inhibitors: Co-administering TAGRISSO with 200 mg itraconazole twice daily (a strong CYP3A4 inhibitor) had no clinically significant effect on the exposure of osimertinib (AUC increased by 24% and Cmax decreased by 20%).</p><p>&nbsp;</p><p><em><u>Effect of gastric acid reducing active substances on osimertinib</u></em></p><p>The exposure of osimertinib was not affected by concurrent administration of a single 80 mg TAGRISSO tablet following 40 mg omeprazole administration for 5 days..</p><p>&nbsp;</p><p><em><u>Active substances whose plasma concentrations may be altered by TAGRISSO</u></em></p><p>Based on <em>in vitro </em>studies, osimertinib is a competitive inhibitor of BCRP transporters.</p><p>In a clinical PK study, co-administration of TAGRISSO with rosuvastatin (sensitive BCRP substrate) increased the AUC and Cmax of rosuvastatin by 35% and 72%, respectively. Patients taking concomitant medicinal products with disposition dependent upon BCRP and with narrow therapeutic index should be closely monitored for signs of changed tolerability of the concomitant medication as a result of increased exposure whilst receiving TAGRISSO (see section 5.2).</p><p>In a clinical PK study, co-administration of TAGRISSO with simvastatin (sensitive CYP3A4 substrate) decreased the AUC and Cmax of simvastatin by 9% and 23% respectively. These changes are small and not likely to be of clinical significance. Clinical PK interactions with CYP3A4 substrates are unlikely. A risk for decreased exposure of hormonal contraceptives cannot be excluded.</p><p>In a clinical Pregnane X Receptor (PXR) interaction study, co-administration of TAGRISSO with fexofenadine (P-gp substrate) increased the AUC and Cmax of fexofenadine by 56% (90% CI 35, 79) and 76% (90% CI 49, 108) after a single dose and 27% (90% CI 11, 46) and 25% (90% CI 6, 48) at steady- state, respectively. Patients taking concomitant medications with disposition dependent upon P-gp and with narrow therapeutic index (e.g. digoxin, dabigatran, aliskiren) should be closely monitored for signs of changed tolerability as a result of increased exposure of the concomitant medication whilst receiving TAGRISSO (see section 5.2).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Based on animal data, TAGRISSO can cause malformations, embryo lethality, and postnatal death at doses resulting in exposures 1.5 times or less the human exposure at the clinical dose of 80 mg daily [see Use in Specific Populations (8.1)].</u></p><p><u>Pregnancy Testing</u></p><p><u>Verify the pregnancy status of females of reproductive potential prior to initiating TAGRISSO.</u></p><p><u>Contraception</u></p><p><u>Females</u></p><p><u>Advise females of reproductive potential to use effective contraception during treatment with TAGRISSO and for 6 weeks after the final dose [see Use in Specific Populations (8.1)].</u></p><p><u>Males</u></p><p><u>Advise male patients with female partners of reproductive potential to use effective contraception during and for 4 months following the final dose of TAGRISSO [see Nonclinical Toxicology (13.1)].</u></p><p><u>Infertility</u></p><p><u>Based on animal studies, TAGRISSO may impair fertility in females and males of reproductive potential. The effects on female fertility showed a trend toward reversibility. It is not known whether the effects on male fertility are reversible </u>Adjuvant Treatment of EGFR Mutation-Positive NSCLC &ndash; Monotherapy</p><p>The safety of TAGRISSO was evaluated in ADAURA, a randomized, double-blind, placebo-controlled trial for the adjuvant treatment of patients with EGFR exon 19 deletions or exon 21 L858R mutation-positive NSCLC who had complete tumor resection, with or without prior adjuvant chemotherapy. At time of DFS analysis, the median duration of exposure to TAGRISSO was 22.5 months.</p><p>&nbsp;</p><p>Serious adverse reactions were reported in 16% of patients treated with TAGRISSO. The most common serious adverse reaction (&ge;1%) was pneumonia (1.5%). Adverse reactions leading to dose reductions occurred in 9% of patients treated with TAGRISSO. The most frequent adverse reactions leading to dose reductions or interruptions were diarrhea (4.5%), stomatitis (3.9%), nail toxicity (1.8%) and rash (1.8%). Adverse reactions leading to permanent discontinuation occurred in 11% of patients treated with TAGRISSO. The most frequent adverse reactions leading to discontinuation of TAGRISSO were interstitial lung disease (2.7%), and rash (1.2%).</p><p>&nbsp;</p><p>Tables 3 and 4 summarize common adverse reactions and laboratory abnormalities which occurred in ADAURA.</p><p>&nbsp;</p><p>Table 3. Adverse Reactions (Numbers in the table are adverse events with no causality established to the Investigational Medicinal Product) Occurring in &ge;10% of Patients Receiving TAGRISSO in ADAURA</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><thead><tr><td rowspan="2"><p><strong>Adverse Reaction</strong></p></td><td colspan="2" style="vertical-align:bottom"><p><strong>TAGRISSO<br />(N=337)</strong></p></td><td colspan="2" style="vertical-align:bottom"><p><strong>PLACEBO<br />(N=343)</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>All Grades</strong></p><p><strong>(%)</strong></p></td><td style="vertical-align:top"><p><strong>Grade 3 or higher</strong><sup>&dagger;</sup></p><p><strong>(%)</strong></p></td><td style="vertical-align:top"><p><strong>All Grades</strong></p><p><strong>(%)</strong></p></td><td style="vertical-align:top"><p><strong>Grade 3 or higher</strong><sup>&dagger;</sup></p><p><strong>(%)</strong></p></td></tr></thead><tbody><tr><td colspan="5" style="vertical-align:top"><p><strong>Gastrointestinal Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Diarrhea<sup>*</sup></p></td><td style="vertical-align:top"><p>47</p></td><td style="vertical-align:top"><p>2.4</p></td><td style="vertical-align:top"><p>20</p></td><td style="vertical-align:top"><p>0.3</p></td></tr><tr><td style="vertical-align:top"><p>Stomatitis<sup>&Dagger;</sup></p></td><td style="vertical-align:top"><p>32</p></td><td style="vertical-align:top"><p>1.8</p></td><td style="vertical-align:top"><p>7</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p>Abdominal Pain<sup>**</sup></p></td><td style="vertical-align:top"><p>12</p></td><td style="vertical-align:top"><p>0.3</p></td><td style="vertical-align:top"><p>7</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Skin Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rash<sup>&sect;</sup></p></td><td style="vertical-align:top"><p>40</p></td><td style="vertical-align:top"><p>0.6</p></td><td style="vertical-align:top"><p>19</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p>Nail toxicity<sup>&para;</sup></p></td><td style="vertical-align:top"><p>37</p></td><td style="vertical-align:top"><p>0.9</p></td><td style="vertical-align:top"><p>3.8</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p>Dry skin<sup>&sect;</sup><sup>&sect;</sup></p></td><td style="vertical-align:top"><p>29</p></td><td style="vertical-align:top"><p>0.3</p></td><td style="vertical-align:top"><p>7</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p>Pruritus<sup>#</sup></p></td><td style="vertical-align:top"><p>19</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>9</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Respiratory, Thoracic and Mediastinal Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Cough<sup>&thorn;</sup></p></td><td style="vertical-align:top"><p>19</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>19</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td colspan="5"><p><strong>Musculoskeletal and Connective Tissue Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Musculoskeletal Pain <sup>&dagger;&dagger;</sup></p></td><td style="vertical-align:top"><p>18</p></td><td style="vertical-align:top"><p>0.3</p></td><td style="vertical-align:top"><p>25</p></td><td style="vertical-align:top"><p>0.3</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Infection and Infestation Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Nasopharyngitis</p></td><td style="vertical-align:top"><p>14</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>10</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p>Upper respiratory tract infection</p></td><td style="vertical-align:top"><p>13</p></td><td style="vertical-align:top"><p>0.6</p></td><td style="vertical-align:top"><p>10</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p>Urinary Tract Infection<sup>&para;&para;</sup></p></td><td style="vertical-align:top"><p>10</p></td><td style="vertical-align:top"><p>0.3</p></td><td style="vertical-align:top"><p>7</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>General Disorders and Administration Site Conditions</strong></p></td></tr><tr><td style="vertical-align:top"><p>Fatigue<sup>b</sup></p></td><td style="vertical-align:top"><p>13</p></td><td style="vertical-align:top"><p>0.6</p></td><td style="vertical-align:top"><p>9</p></td><td style="vertical-align:top"><p>0.3</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Nervous System Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Dizziness <sup>##</sup></p></td><td style="vertical-align:top"><p>10</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>9</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Metabolism and Nutrition Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Decreased appetite</p></td><td style="vertical-align:top"><p>13</p></td><td style="vertical-align:top"><p>0.6</p></td><td style="vertical-align:top"><p>3.8</p></td><td style="vertical-align:top"><p>0</p></td></tr></tbody></table><p><sup>bb</sup>NCI CTCAE v4.0.</p><p><sup>&dagger;</sup>All events were grade 3.</p><p><sup>*</sup>Includes diarrhea, colitis, enterocolitis, enteritis.</p><p><sup>&Dagger;</sup>Includes aphthous ulcer, cheilitis, gingival ulceration, glossitis, tongue ulceration, stomatitis and mouth ulceration.</p><p><sup>**</sup>Includes abdominal discomfort, abdominal pain, abdominal lower pain, abdominal upper pain, epigastric discomfort, hepatic pain.</p><p><sup>&sect;</sup>Includes rash, rash generalized, rash erythematous, rash macular, rash maculo-papular, rash papular, rash pustular, rash pruritic, rash vesicular, rash follicular, erythema, folliculitis, acne, dermatitis, dermatitis acneiform, dermatitis bullous, dermatitis exfoliative generalized, drug eruption, eczema, eczema asteatotic, lichen planus, skin erosion, pustule.</p><p><sup>&para;</sup>Includes nail bed disorder, nail bed inflammation, nail bed infection, nail discoloration, nail pigmentation, nail disorder, nail toxicity, nail dystrophy, nail infection, nail ridging, onychalgia, onychoclasis, onycholysis, onychomadesis, onychomalacia, paronychia.</p><p><sup>&sect;&sect;</sup>Includes dry skin, skin fissures, xerosis, eczema, xeroderma.</p><p><sup>#</sup>Includes pruritus, pruritus generalized, eyelid pruritus.</p><p><sup>&thorn;</sup>Includes cough, productive cough, upper-airway cough syndrome.</p><p><sup>&dagger;&dagger;</sup>Includes arthralgia, arthritis, back pain, bone pain, musculoskeletal chest pain, musculoskeletal pain, myalgia, neck pain, non-cardiac chest pain, pain in extremity, and spinal pain.</p><p><sup>&para;&para;</sup>Includes cystitis, urinary tract infection, and urinary tract infection bacterial.</p><p><sup>b</sup>Includes asthenia, fatigue.</p><p><sup>##</sup>Includes dizziness, vertigo, and vertigo positional.</p><p>&nbsp;</p><p><sup>&Dagger;</sup>Includes rash, rash generalized, rash erythematous, rash macular, rash maculo-papular, rash papular, rash pustular, erythema, folliculitis, acne, dermatitis, acneiform dermatitis, pustule.</p><p><sup>&sect;</sup><sup> </sup>Includes dry skin, eczema, skin fissures, xerosis.</p><p><sup>&para;</sup>Includes nail disorders, nail bed disorders, nail bed inflammation, nail bed tenderness, nail discoloration, nail disorder, nail dystrophy, nail infection, nail ridging, nail toxicity, onychalgia, onychoclasis, onycholysis, onychomadesis, paronychia.</p><p><sup>#</sup>Includes pruritus, pruritus generalized, eyelid pruritus.</p><p><sup>&thorn;</sup>Includes fatigue, asthenia.</p><p>&nbsp;</p><p>Clinically relevant adverse reactions in AURA3 in &lt;10% of patients receiving TAGRISSO were epistaxis (5%), interstitial lung disease (3.9%), alopecia (3.6%), urticaria (2.9%), palmar-plantar erythrodysesthesia syndrome (1.8%), QTc interval prolongation (1.4%), keratitis (1.1%), and erythema multiforme (0.7%). QTc interval prolongation represents the incidence of patients who had a QTcF prolongation &gt;500 msec.</p><p>Table 10. Laboratory Abnormalities Worsening from Baseline in &ge;20% of Patients in AURA3</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><thead><tr><td rowspan="2"><p><strong>Laboratory Abnormality<sup>*, &dagger;</sup></strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>TAGRISSO</strong></p><p><strong>(N=279)</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>Chemotherapy (Pemetrexed/Cisplatin or Pemetrexed/Carboplatin)</strong></p><p><strong>(N=131)</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>All Grades (%)</strong></p></td><td style="vertical-align:top"><p><strong>Grade 3 or Grade 4 (%)</strong></p></td><td style="vertical-align:top"><p><strong>All Grades</strong></p><p><strong>(%)</strong></p></td><td style="vertical-align:top"><p><strong>Grade 3 or Grade 4</strong></p><p><strong>(%)</strong></p></td></tr></thead><tbody><tr><td colspan="5" style="vertical-align:top"><p><strong>Hematology</strong></p></td></tr><tr><td style="vertical-align:top"><p>Anemia</p></td><td style="vertical-align:top"><p>43</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>79</p></td><td style="vertical-align:top"><p>3.1</p></td></tr><tr><td style="vertical-align:top"><p>Lymphopenia</p></td><td style="vertical-align:top"><p>63</p></td><td style="vertical-align:top"><p>8</p></td><td style="vertical-align:top"><p>61</p></td><td style="vertical-align:top"><p>10</p></td></tr><tr><td style="vertical-align:top"><p>Thrombocytopenia</p></td><td style="vertical-align:top"><p>46</p></td><td style="vertical-align:top"><p>0.7</p></td><td style="vertical-align:top"><p>48</p></td><td style="vertical-align:top"><p>7</p></td></tr><tr><td style="vertical-align:top"><p>Neutropenia</p></td><td style="vertical-align:top"><p>27</p></td><td style="vertical-align:top"><p>2.2</p></td><td style="vertical-align:top"><p>49</p></td><td style="vertical-align:top"><p>12</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Chemistry</strong></p></td></tr><tr><td style="vertical-align:top"><p>Hypermagnesemia<sup>&dagger;</sup></p></td><td style="vertical-align:top"><p>27</p></td><td style="vertical-align:top"><p>1.8</p></td><td style="vertical-align:top"><p>9</p></td><td style="vertical-align:top"><p>1.5</p></td></tr><tr><td style="vertical-align:top"><p>Hyponatremia<sup>&dagger;</sup></p></td><td style="vertical-align:top"><p>26</p></td><td style="vertical-align:top"><p>2.2</p></td><td style="vertical-align:top"><p>36</p></td><td style="vertical-align:top"><p>1.5</p></td></tr><tr><td style="vertical-align:top"><p>Hyperglycemia<sup>&Dagger;</sup></p></td><td style="vertical-align:top"><p>20</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>NA</p></td><td style="vertical-align:top"><p>NA</p></td></tr><tr><td style="vertical-align:top"><p>Hypokalemia<sup>&dagger;</sup></p></td><td style="vertical-align:top"><p>9</p></td><td style="vertical-align:top"><p>1.4</p></td><td style="vertical-align:top"><p>18</p></td><td style="vertical-align:top"><p>1.5</p></td></tr></tbody></table><p>NA=not applicable</p><p><sup>*</sup>NCI CTCAE v4.0</p><p><sup>&dagger;</sup>Each test incidence, except for hyperglycemia, is based on the number of patients who had both baseline and at least one on-study laboratory measurement available (TAGRISSO 279, Chemotherapy comparator 131)</p><p><sup>&Dagger;</sup>Hyperglycemia<sup> </sup>is based on the number of patients who had both baseline and at least one on-study laboratory measurement available (TAGRISSO 270, Chemotherapy 5; fasting glucose was not a protocol requirement for patients in the chemotherapy arm)</p><p>&nbsp;</p><p>Clinically relevant laboratory abnormalities in AURA3 that occurred in &lt;20% of patients receiving TAGRISSO included increased blood creatinine (7%).</p><p><u>Other Clinical Trials Experience</u></p><p>The following adverse reaction has been reported following administration of TAGRISSO: increased blood creatine phosphokinase.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>TAGRISSO has no or negligible influence on the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In addition to the 1813 patients, certain subsections in the Special warnings and precautions for use describe adverse reactions observed with exposure to TAGRISSO monotherapy (80 mg orally once daily until disease progression or unacceptable toxicity) following definitive platinum-based chemoradiation therapy (n=143) in the LAURA study.</p><p>The data described below reflect exposure to TAGRISSO (80&nbsp;mg daily) in 337 patients with EGFR mutation-positive resectable NSCLC, 143 patients with EGFR mutation-positive locally advanced, unresectable (stage III) NSCLC, and 833 patients with EGFR mutation-positive locally advanced or metastatic NSCLC in five randomized, controlled trials [ADAURA (n=337), LAURA (n=143), FLAURA (n=279), FLAURA2 (monotherapy arm; n=275), and AURA3 (n=279)]. The data also reflect exposure to TAGRISSO at the recommended dose of 80&nbsp;mg daily given in combination with pemetrexed and platinum-based chemotherapy in 276 patients with EGFR mutation-positive locally advanced or metastatic NSCLC in one randomized controlled trial [FLAURA2 (n=276)]. Patients with a history of interstitial lung disease, drug induced interstitial disease or radiation pneumonitis that required steroid treatment, serious arrhythmia or baseline QTc interval greater than 470&nbsp;msec on electrocardiogram were excluded from enrollment in these studies.</p><p><u>&nbsp;</u></p><p><u>Adjuvant Treatment of EGFR Mutation-Positive NSCLC &ndash; </u><u>Monotherapy</u></p><p>The safety of TAGRISSO was evaluated in ADAURA, a randomized, double-blind, placebo-controlled trial for the adjuvant treatment of patients with EGFR exon 19 deletions or exon 21 L858R mutation-positive NSCLC who had complete tumor resection, with or without prior adjuvant chemotherapy. At time of DFS analysis, the median duration of exposure to TAGRISSO was 22.5 months.</p><p>&nbsp;</p><p>Serious adverse reactions were reported in 16% of patients treated with TAGRISSO. The most common serious adverse reaction (&ge;1%) was pneumonia (1.5%). Adverse reactions leading to dose reductions occurred in 9% of patients treated with TAGRISSO. The most frequent adverse reactions leading to dose reductions or interruptions were diarrhea (4.5%), stomatitis (3.9%), nail toxicity (1.8%) and rash (1.8%). Adverse reactions leading to permanent discontinuation occurred in 11% of patients treated with TAGRISSO. The most frequent adverse reactions leading to discontinuation of TAGRISSO were interstitial lung disease (2.7%), and rash (1.2%).</p><p>&nbsp;</p><p>Tables 3 and 4 summarize common adverse reactions and laboratory abnormalities which occurred in ADAURA.</p><p>&nbsp;</p><p>Table 3. Adverse Reactions (<strong>Numbers in the table are adverse events with no causality established to the Investigational Medicinal Product)</strong> Occurring in &ge;10% of Patients Receiving TAGRISSO in ADAURA<sup>bb</sup></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><thead><tr><td rowspan="2"><p><strong>Adverse Reaction</strong></p></td><td colspan="2" style="vertical-align:bottom"><p><strong>TAGRISSO<br />(N=337)</strong></p></td><td colspan="2" style="vertical-align:bottom"><p><strong>PLACEBO<br />(N=343)</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>All Grades</strong></p><p><strong>(%)</strong></p></td><td style="vertical-align:top"><p><strong>Grade 3 or higher</strong><sup>&dagger;</sup></p><p><strong>(%)</strong></p></td><td style="vertical-align:top"><p><strong>All Grades</strong></p><p><strong>(%)</strong></p></td><td style="vertical-align:top"><p><strong>Grade 3 or higher</strong><sup>&dagger;</sup></p><p><strong>(%)</strong></p></td></tr></thead><tbody><tr><td colspan="5" style="vertical-align:top"><p><strong>Gastrointestinal Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Diarrhea<sup>*</sup></p></td><td style="vertical-align:top"><p>47</p></td><td style="vertical-align:top"><p>2.4</p></td><td style="vertical-align:top"><p>20</p></td><td style="vertical-align:top"><p>0.3</p></td></tr><tr><td style="vertical-align:top"><p>Stomatitis<sup>&Dagger;</sup></p></td><td style="vertical-align:top"><p>32</p></td><td style="vertical-align:top"><p>1.8</p></td><td style="vertical-align:top"><p>7</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p>Abdominal Pain<sup>**</sup></p></td><td style="vertical-align:top"><p>12</p></td><td style="vertical-align:top"><p>0.3</p></td><td style="vertical-align:top"><p>7</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Skin Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rash<sup>&sect;</sup></p></td><td style="vertical-align:top"><p>40</p></td><td style="vertical-align:top"><p>0.6</p></td><td style="vertical-align:top"><p>19</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p>Nail toxicity<sup>&para;</sup></p></td><td style="vertical-align:top"><p>37</p></td><td style="vertical-align:top"><p>0.9</p></td><td style="vertical-align:top"><p>3.8</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p>Dry skin<sup>&sect;</sup><sup>&sect;</sup></p></td><td style="vertical-align:top"><p>29</p></td><td style="vertical-align:top"><p>0.3</p></td><td style="vertical-align:top"><p>7</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p>Pruritus<sup>#</sup></p></td><td style="vertical-align:top"><p>19</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>9</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Respiratory, Thoracic and Mediastinal Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Cough<sup>&thorn;</sup></p></td><td style="vertical-align:top"><p>19</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>19</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td colspan="5"><p><strong>Musculoskeletal and Connective Tissue Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Musculoskeletal Pain <sup>&dagger;&dagger;</sup></p></td><td style="vertical-align:top"><p>18</p></td><td style="vertical-align:top"><p>0.3</p></td><td style="vertical-align:top"><p>25</p></td><td style="vertical-align:top"><p>0.3</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Infection and Infestation Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Nasopharyngitis</p></td><td style="vertical-align:top"><p>14</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>10</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p>Upper respiratory tract infection</p></td><td style="vertical-align:top"><p>13</p></td><td style="vertical-align:top"><p>0.6</p></td><td style="vertical-align:top"><p>10</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p>Urinary Tract Infection<sup>&para;&para;</sup></p></td><td style="vertical-align:top"><p>10</p></td><td style="vertical-align:top"><p>0.3</p></td><td style="vertical-align:top"><p>7</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>General Disorders and Administration Site Conditions</strong></p></td></tr><tr><td style="vertical-align:top"><p>Fatigue<sup>b</sup></p></td><td style="vertical-align:top"><p>13</p></td><td style="vertical-align:top"><p>0.6</p></td><td style="vertical-align:top"><p>9</p></td><td style="vertical-align:top"><p>0.3</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Nervous System Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Dizziness <sup>##</sup></p></td><td style="vertical-align:top"><p>10</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>9</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Metabolism and Nutrition Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Decreased appetite</p></td><td style="vertical-align:top"><p>13</p></td><td style="vertical-align:top"><p>0.6</p></td><td style="vertical-align:top"><p>3.8</p></td><td style="vertical-align:top"><p>0</p></td></tr></tbody></table><p><sup>bb</sup>NCI CTCAE v4.0.</p><p><sup>&dagger;</sup>All events were grade 3.</p><p><sup>*</sup>Includes diarrhea, colitis, enterocolitis, enteritis.</p><p><sup>&Dagger;</sup>Includes aphthous ulcer, cheilitis, gingival ulceration, glossitis, tongue ulceration, stomatitis and mouth ulceration.</p><p><sup>**</sup>Includes abdominal discomfort, abdominal pain, abdominal lower pain, abdominal upper pain, epigastric discomfort, hepatic pain.</p><p><sup>&sect;</sup>Includes rash, rash generalized, rash erythematous, rash macular, rash maculo-papular, rash papular, rash pustular, rash pruritic, rash vesicular, rash follicular, erythema, folliculitis, acne, dermatitis, dermatitis acneiform, dermatitis bullous, dermatitis exfoliative generalized, drug eruption, eczema, eczema asteatotic, lichen planus, skin erosion, pustule.</p><p><sup>&para;</sup>Includes nail bed disorder, nail bed inflammation, nail bed infection, nail discoloration, nail pigmentation, nail disorder, nail toxicity, nail dystrophy, nail infection, nail ridging, onychalgia, onychoclasis, onycholysis, onychomadesis, onychomalacia, paronychia.</p><p><sup>&sect;&sect;</sup>Includes dry skin, skin fissures, xerosis, eczema, xeroderma.</p><p><sup>#</sup>Includes pruritus, pruritus generalized, eyelid pruritus.</p><p><sup>&thorn;</sup>Includes cough, productive cough, upper-airway cough syndrome.</p><p><sup>&dagger;&dagger;</sup>Includes arthralgia, arthritis, back pain, bone pain, musculoskeletal chest pain, musculoskeletal pain, myalgia, neck pain, non-cardiac chest pain, pain in extremity, and spinal pain.</p><p><sup>&para;&para;</sup>Includes cystitis, urinary tract infection, and urinary tract infection bacterial.</p><p><sup>b</sup>Includes asthenia, fatigue.</p><p><sup>##</sup>Includes dizziness, vertigo, and vertigo positional.</p><p><strong>&nbsp;</strong></p><p>Clinically relevant adverse reactions in ADAURA in &lt;10% of patients receiving TAGRISSO were alopecia (6%), epistaxis (6%), interstitial lung disease (3%), palmar-plantar erythrodysesthesia syndrome (1.8%), skin hyperpigmentation (1.8%), &nbsp;urticaria (1.5%), keratitis (0.6%), QTc interval prolongation (0.6%), and erythema multiforme (0.3%). QTc interval prolongation represents the incidence of patients who had a QTcF prolongation &gt;500 msec.</p><p>Table 4. Laboratory Abnormalities Worsening from Baseline in &ge;20% of Patients in ADAURA</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><thead><tr><td rowspan="2"><p><strong>Laboratory Abnormality<sup>*, &dagger;</sup></strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>TAGRISSO</strong></p><p><strong>(N=337)</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>PLACEBO</strong></p><p><strong>(N=343)</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>All Grades (%)</strong></p></td><td style="vertical-align:top"><p><strong>Grade 3 or Grade 4 (%)</strong></p></td><td style="vertical-align:top"><p><strong>All Grades</strong></p><p><strong>(%)</strong></p></td><td style="vertical-align:top"><p><strong>Grade 3 or Grade 4</strong></p><p><strong>(%)</strong></p></td></tr></thead><tbody><tr><td colspan="5" style="vertical-align:top"><p><strong>Hematology</strong></p></td></tr><tr><td style="vertical-align:top"><p>Leukopenia</p></td><td style="vertical-align:top"><p>54</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>25</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p>Thrombocytopenia</p></td><td style="vertical-align:top"><p>47</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>7</p></td><td style="vertical-align:top"><p>0.3</p></td></tr><tr><td style="vertical-align:top"><p>Lymphopenia</p></td><td style="vertical-align:top"><p>44</p></td><td style="vertical-align:top"><p>3.4</p></td><td style="vertical-align:top"><p>14</p></td><td style="vertical-align:top"><p>0.9</p></td></tr><tr><td style="vertical-align:top"><p>Anemia</p></td><td style="vertical-align:top"><p>30</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>12</p></td><td style="vertical-align:top"><p>0.3</p></td></tr><tr><td style="vertical-align:top"><p>Neutropenia</p></td><td style="vertical-align:top"><p>26</p></td><td style="vertical-align:top"><p>0.6</p></td><td style="vertical-align:top"><p>10</p></td><td style="vertical-align:top"><p>0.3</p></td></tr><tr><td colspan="5"><p><strong>Chemistry</strong></p></td></tr><tr><td style="vertical-align:top"><p>Hyperglycemia</p></td><td style="vertical-align:top"><p>25</p></td><td style="vertical-align:top"><p>2.3</p></td><td style="vertical-align:top"><p>30</p></td><td style="vertical-align:top"><p>0.9</p></td></tr><tr><td style="vertical-align:top"><p>Hypermagnesemia</p></td><td style="vertical-align:top"><p>24</p></td><td style="vertical-align:top"><p>1.3</p></td><td style="vertical-align:top"><p>14</p></td><td style="vertical-align:top"><p>1.5</p></td></tr><tr><td style="vertical-align:top"><p>Hyponatremia</p></td><td style="vertical-align:top"><p>20</p></td><td style="vertical-align:top"><p>1.8</p></td><td style="vertical-align:top"><p>16</p></td><td style="vertical-align:top"><p>1.5</p></td></tr></tbody></table><p><sup>*</sup>NCI CTCAE v4.0</p><p><strong><sup>&dagger;</sup></strong>Based on the number of patients with available follow-up laboratory data.</p><p>&nbsp;</p><p>Laboratory abnormalities in ADAURA that occurred in &lt;20% of patients receiving TAGRISSO was increased blood creatinine (10%).</p><p>Locally Advanced, Unresectable (Stage III) EGFR Mutation Positive NSCLC</p><p>The safety of TAGRISSO was evaluated in LAURA, a double blind, randomized (2:1), placebo controlled study conducted in 216 patients with EGFR exon 19 deletions or exon 21 L858R mutation positive, locally advanced, unresectable (stage III) NSCLC, who had not progressed during or following definitive platinum based chemoradiation therapy. Among patients who received TAGRISSO, 81% were exposed for 6 months or longer and 74% were exposed for one year or longer.</p><p>Serious adverse reactions were reported in 38% of patients treated with TAGRISSO. The most common serious adverse reactions (&ge;1%) included ILD/pneumonitis (13%), pneumonia (6%) and gastroenteritis (1.4%). Fatal adverse reactions occurred in 1.4% of patients who received TAGRISSO due to pneumonia (0.7%) and ILD/pneumonitis (0.7%).</p><p>Permanent discontinuation of TAGRISSO due to an adverse reaction occurred in 13% of patients. The adverse reactions resulting in permanent discontinuation of TAGRISSO in &gt; 1 patient were ILD/pneumonitis (7%) and pneumonia (1.4%).</p><p>Dosage interruptions of TAGRISSO due to an adverse reaction occurred in 56% of patients. The adverse reactions requiring dosage interruption in &ge;2% of patients were ILD/pneumonitis (35%), pneumonia (6%), COVID-19 (4.2%), neutropenia (2.1%), and QTc interval prolongation (2.1%).</p><p>Dose reductions of TAGRISSO due to an adverse reaction occurred in 8% of patients.</p><p>The most common adverse reactions, including laboratory abnormalities worsening from baseline, were lymphopenia, leukopenia, ILD/pneumonitis, thrombocytopenia, neutropenia, rash, diarrhea, nail toxicity, musculoskeletal pain, cough, and COVID-19.</p><p>Tables 5 and 6 summarize common adverse reactions and laboratory abnormalities which occurred in LAURA.</p><p>&nbsp;</p><p>Table 5. Adverse Reactions in &ge;10% of Patients Receiving TAGRISSO in LAURA*</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><thead><tr><td rowspan="2" style="vertical-align:top"><p><strong>Adverse Reaction</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>TAGRISSO</strong></p><p><strong>(N=143)</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>Placebo</strong></p><p><strong>(N=73)</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Any Grade (%)</strong></p></td><td style="vertical-align:top"><p><strong>Grade 3 or 4(%)</strong></p></td><td style="vertical-align:top"><p><strong>Any Grade (%)</strong></p></td><td style="vertical-align:top"><p><strong>Grade 3 or 4</strong></p><p><strong>(%)</strong></p></td></tr></thead><tbody><tr><td colspan="5" style="vertical-align:top"><p><strong>Respiratory, Thoracic and Mediastinal Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>ILD/pneumonitis<sup>1</sup></p></td><td style="vertical-align:top"><p>56</p></td><td style="vertical-align:top"><p>3.5</p></td><td style="vertical-align:top"><p>38</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p>Cough<sup>2</sup></p></td><td style="vertical-align:top"><p>20</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>15</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Skin Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rash<sup>5</sup></p></td><td style="vertical-align:top"><p>39</p></td><td style="vertical-align:top"><p>0.7</p></td><td style="vertical-align:top"><p>19</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p>Nail toxicity<sup>6</sup></p></td><td style="vertical-align:top"><p>23</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>1.4</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p>Dry skin<sup>7</sup></p></td><td style="vertical-align:top"><p>17</p></td><td style="vertical-align:top"><p>0.7</p></td><td style="vertical-align:top"><p>5</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p>Pruritus</p></td><td style="vertical-align:top"><p>13</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>7</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Gastrointestinal Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Diarrhea<sup>3</sup></p></td><td style="vertical-align:top"><p>36</p></td><td style="vertical-align:top"><p>2.1</p></td><td style="vertical-align:top"><p>14</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p>Stomatitis<sup>4 </sup></p></td><td style="vertical-align:top"><p>15</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>5</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Musculoskeletal and Connective Tissue Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Musculoskeletal pain<sup>8</sup></p></td><td style="vertical-align:top"><p>20</p></td><td style="vertical-align:top"><p>0.7</p></td><td style="vertical-align:top"><p>26</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Infection and Infestation Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>COVID-19<sup>9</sup></p></td><td style="vertical-align:top"><p>20</p></td><td style="vertical-align:top"><p>0.7</p></td><td style="vertical-align:top"><p>10</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p>Pneumonia<sup>10</sup></p></td><td style="vertical-align:top"><p>15</p></td><td style="vertical-align:top"><p>3.5</p></td><td style="vertical-align:top"><p>10</p></td><td style="vertical-align:top"><p>5</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Metabolism and Nutrition Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Decreased appetite</p></td><td style="vertical-align:top"><p>15</p></td><td style="vertical-align:top"><p>0.7</p></td><td style="vertical-align:top"><p>5</p></td><td style="vertical-align:top"><p>0</p></td></tr></tbody></table><p><u>*NCI CTCAE v5.0</u></p><p><u>1 Includes radiation pneumonitis, radiation lung fibrosis, pneumonitis, interstitial lung disease (ILD), pulmonary fibrosis.</u></p><p><u>2 Includes cough, productive cough.</u></p><p><u>3 Includes diarrhea, enteritis.</u></p><p><u>4 Includes stomatitis, aphthous ulceration, mouth ulceration.</u></p><p><u>5 Includes rash, maculo-papular rash, pustular rash, pruritic rash, folliculitis, papule, dermatitis, acneiform dermatitis, atopic dermatitis, eczema, asteatotic eczema, acne, urticaria.</u></p><p><u>6 Includes nail bed disorder, nail disorder, nail discoloration, nail infection, onychoclasis, paronychia.</u></p><p><u>7 Includes dry skin, skin fissures, senile xerosis, xeroderma.</u></p><p><u>8 Includes musculoskeletal chest pain, myalgia, arthritis, arthralgia, back pain, bone pain, musculoskeletal pain, neck pain, pain in extremity, spinal osteoarthritis.</u></p><p><u>9 Includes COVID-19 and COVID-19 pneumonia.</u></p><p><u>10 Includes pneumonia, aspiration pneumonia, viral pneumonia, Pneumocystis jiroveci pneumonia, Haemophilus pneumonia, lower respiratory tract infection.</u></p><p><u>&nbsp;</u></p><p><u>Clinically relevant adverse reactions in LAURA in &lt;10% of patients receiving TAGRISSO were dyspnea (8%), urinary tract infection (8%), alopecia (1.4%), urticaria (1.4%), epistaxis (0.7%), keratitis (0.7%), and QTc interval prolongation (0.7%). QTc interval prolongation represents the incidence of patients who had a QTc prolongation &gt;500 msec.</u></p><p>&nbsp;</p><p><u>Table 6. Laboratory Abnormalities Worsening from Baseline in &ge;20% of Patients in LAURA</u></p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><thead><tr><td rowspan="2"><p><strong>Laboratory Abnormality<sup>*,&dagger;</sup></strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>TAGRISSO</strong></p><p><strong>(N=143)</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>Placebo</strong></p><p><strong>(N=73)</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>All Grades (%)</strong></p></td><td style="vertical-align:top"><p><strong>Grade 3 or 4</strong></p><p><strong>(%)</strong></p></td><td style="vertical-align:top"><p><strong>All Grades </strong></p><p><strong>(%)</strong></p></td><td style="vertical-align:top"><p><strong>Grade 3 or 4</strong></p><p><strong>(%)</strong></p></td></tr></thead><tbody><tr><td colspan="5" style="vertical-align:top"><p><strong>Hematology</strong></p></td></tr><tr><td style="vertical-align:top"><p>Lymphopenia</p></td><td style="vertical-align:top"><p>70</p></td><td style="vertical-align:top"><p>3.5</p></td><td style="vertical-align:top"><p>40</p></td><td style="vertical-align:top"><p>1.4</p></td></tr><tr><td style="vertical-align:top"><p>Leukopenia</p></td><td style="vertical-align:top"><p>66</p></td><td style="vertical-align:top"><p>2.8</p></td><td style="vertical-align:top"><p>24</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p>Thrombocytopenia</p></td><td style="vertical-align:top"><p>51</p></td><td style="vertical-align:top"><p>1.4</p></td><td style="vertical-align:top"><p>8</p></td><td style="vertical-align:top"><p>1.4</p></td></tr><tr><td style="vertical-align:top"><p>Neutropenia</p></td><td style="vertical-align:top"><p>42</p></td><td style="vertical-align:top"><p>2.1</p></td><td style="vertical-align:top"><p>15</p></td><td style="vertical-align:top"><p>1.4</p></td></tr></tbody></table><p>&nbsp;</p><p><u>*NCI CTCAE v5.0</u></p><p><u>&dagger;Each test incidence is based on the number of patients who had both baseline and at least one on-study laboratory measurement available (TAGRISSO arm: 142 and placebo arm: 72).</u></p><p>&nbsp;</p><p><u>A clinically relevant laboratory abnormality in LAURA that occurred in &lt;20% of patients receiving TAGRISSO was increased blood creatinine (19%).</u></p><p>&nbsp;</p><p><u>Previously Untreated EGFR Mutation-Positive Metastatic Non-Small Cell Lung Cancer &ndash; Monotherapy</u></p><p>&nbsp;</p><p>The safety of TAGRISSO was evaluated in FLAURA, a multicenter international double-blind randomized (1:1) active-controlled trial conducted in 556 patients with EGFR exon 19 deletion or exon 21 L858R mutation-positive, unresectable or metastatic NSCLC who had not received previous systemic treatment for advanced disease. The median duration of exposure to TAGRISSO was 16.2 months.</p><p>Serious adverse reactions were reported in 4% of patients treated with TAGRISSO; the most common serious adverse reactions (&ge;1%) were pneumonia (2.9%), ILD/pneumonitis (2.1%), and pulmonary embolism (1.8%). Dose reductions occurred in 2.9% of patients treated with TAGRISSO. The most frequent adverse reactions leading to dose reductions or interruptions were prolongation of the QT interval as assessed by ECG (4.3%), diarrhea (2.5%), and lymphopenia (1.1%). Adverse reactions leading to permanent discontinuation occurred in 13% of patients treated with TAGRISSO. The most frequent adverse reaction leading to discontinuation of TAGRISSO was ILD/pneumonitis (3.9%).</p><p>Tables 7 and 8 summarize common adverse reactions and laboratory abnormalities which occurred in FLAURA.</p><p>Table 7. Adverse Reactions (<strong>numbers in the table are adverse events with no causality established to the Investigational Medicinal Product)</strong> Occurring in &ge;10% of Patients Receiving TAGRISSO in FLAURA*</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><thead><tr><td rowspan="2"><p><strong>Adverse Reaction</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>TAGRISSO</strong></p><p><strong>(N=279)</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>EGFR TKI comparator</strong></p><p><strong>(gefitinib or erlotinib)</strong></p><p><strong>(N=277)</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Any Grade (%)</strong></p></td><td style="vertical-align:top"><p><strong>Grade 3 or higher</strong></p><p><strong>(%)</strong></p></td><td style="vertical-align:top"><p><strong>Any Grade (%)</strong></p></td><td style="vertical-align:top"><p><strong>Grade 3 or higher</strong></p><p><strong>(%)</strong></p></td></tr></thead><tbody><tr><td colspan="5" style="vertical-align:top"><p><strong>Gastrointestinal Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Diarrhea<sup>&dagger; </sup></p></td><td style="vertical-align:top"><p>58</p></td><td style="vertical-align:top"><p>2.2</p></td><td style="vertical-align:top"><p>57</p></td><td style="vertical-align:top"><p>2.5</p></td></tr><tr><td style="vertical-align:top"><p>Stomatitis<sup>‖ </sup></p></td><td style="vertical-align:top"><p>32</p></td><td style="vertical-align:top"><p>0.7</p></td><td style="vertical-align:top"><p>22</p></td><td style="vertical-align:top"><p>1.1</p></td></tr><tr><td style="vertical-align:top"><p>Nausea</p></td><td style="vertical-align:top"><p>14</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>19</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p>Constipation</p></td><td style="vertical-align:top"><p>15</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>13</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p>Vomiting</p></td><td style="vertical-align:top"><p>11</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>11</p></td><td style="vertical-align:top"><p>1.4</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Skin Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rash<sup>&Dagger; </sup></p></td><td style="vertical-align:top"><p>58</p></td><td style="vertical-align:top"><p>1.1</p></td><td style="vertical-align:top"><p>78</p></td><td style="vertical-align:top"><p>7</p></td></tr><tr><td style="vertical-align:top"><p>Dry skin<sup>&sect; </sup></p></td><td style="vertical-align:top"><p>36</p></td><td style="vertical-align:top"><p>0.4</p></td><td style="vertical-align:top"><p>36</p></td><td style="vertical-align:top"><p>1.1</p></td></tr><tr><td style="vertical-align:top"><p>Nail toxicity<sup>&para;</sup></p></td><td style="vertical-align:top"><p>35</p></td><td style="vertical-align:top"><p>0.4</p></td><td style="vertical-align:top"><p>33</p></td><td style="vertical-align:top"><p>0.7</p></td></tr><tr><td style="vertical-align:top"><p>Pruritus<sup># </sup></p></td><td style="vertical-align:top"><p>17</p></td><td style="vertical-align:top"><p>0.4</p></td><td style="vertical-align:top"><p>17</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>General Disorders and Administration Site Conditions</strong></p></td></tr><tr><td style="vertical-align:top"><p>Fatigue<sup>&thorn;</sup></p></td><td style="vertical-align:top"><p>21</p></td><td style="vertical-align:top"><p>1.4</p></td><td style="vertical-align:top"><p>15</p></td><td style="vertical-align:top"><p>1.4</p></td></tr><tr><td style="vertical-align:top"><p>Pyrexia</p></td><td style="vertical-align:top"><p>10</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>4</p></td><td style="vertical-align:top"><p>0.4</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Metabolism and Nutrition Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Decreased appetite</p></td><td style="vertical-align:top"><p>20</p></td><td style="vertical-align:top"><p>2.5</p></td><td style="vertical-align:top"><p>19</p></td><td style="vertical-align:top"><p>1.8</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Respiratory, Thoracic and Mediastinal Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Cough</p></td><td style="vertical-align:top"><p>17</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>15</p></td><td style="vertical-align:top"><p>0.4</p></td></tr><tr><td style="vertical-align:top"><p>Dyspnea</p></td><td style="vertical-align:top"><p>13</p></td><td style="vertical-align:top"><p>0.4</p></td><td style="vertical-align:top"><p>7</p></td><td style="vertical-align:top"><p>1.4</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Neurologic Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Headache</p></td><td style="vertical-align:top"><p>12</p></td><td style="vertical-align:top"><p>0.4</p></td><td style="vertical-align:top"><p>7</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Cardiac Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Prolonged QT Interval<sup>b</sup></p></td><td style="vertical-align:top"><p>10</p></td><td style="vertical-align:top"><p>2.2</p></td><td style="vertical-align:top"><p>4</p></td><td style="vertical-align:top"><p>0.7</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Infection and Infestation Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Upper Respiratory Tract Infection</p></td><td style="vertical-align:top"><p>10</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>7</p></td><td style="vertical-align:top"><p>0</p></td></tr></tbody></table><p><sup>*</sup>NCI CTCAE v4.0</p><p><sup>&dagger;</sup>One grade 5 (fatal) event was reported (diarrhea) for EGFR TKI comparator.</p><p><sup>‖</sup>Includes stomatitis and mouth ulceration.</p><p><sup>&Dagger;</sup>Includes rash, rash generalized, rash erythematous, rash macular, rash maculo-papular, rash papular, rash pustular, rash pruritic, rash vesicular, rash follicular, erythema, folliculitis, acne, dermatitis, dermatitis acneiform, drug eruption, skin erosion, pustule.</p><p><sup>&sect;</sup>Includes dry skin, skin fissures, xerosis, eczema, xeroderma.</p><p><sup>&para;</sup>Includes nail bed disorder, nail bed inflammation, nail bed infection, nail discoloration, nail pigmentation, nail disorder, nail toxicity, nail dystrophy, nail infection, nail ridging, onychalgia, onychoclasis, onycholysis, onychomadesis, onychomalacia, paronychia.</p><p><sup>#</sup>Includes pruritus, pruritus generalized, eyelid pruritus.</p><p><sup>&thorn;</sup>Includes fatigue, asthenia.</p><p><sup>b</sup> Includes prolonged QT interval reported as adverse reaction.</p><p>&nbsp;</p><p>Clinically relevant adverse reactions in FLAURA in &lt;10% of patients receiving TAGRISSO were alopecia (7%), epistaxis (6%), interstitial lung disease (3.9%), urticaria (2.2%), palmar-plantar erythrodysesthesia syndrome (1.4%) and skin hyperpigmentation (0.4%). , QTc interval prolongation (1.1%), and keratitis (0.4%). QTc interval prolongation represents the incidence of patients who had a QTcF prolongation &gt;500 msec.</p><p>&nbsp;</p><p>Table 8. Laboratory Abnormalities Worsening from Baseline in &ge;20% of Patients in FLAURA</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><thead><tr><td rowspan="2"><p><strong>Laboratory Abnormality<sup>*, &dagger;</sup></strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>TAGRISSO</strong></p><p><strong>(N=279)</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>EGFR TKI comparator</strong></p><p><strong>(gefitinib or erlotinib)</strong></p><p><strong>(N=277)</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>All Grades (%)</strong></p></td><td style="vertical-align:top"><p><strong>Grade 3 or Grade 4</strong></p><p><strong>(%)</strong></p></td><td style="vertical-align:top"><p><strong>All Grades </strong></p><p><strong>(%)</strong></p></td><td style="vertical-align:top"><p><strong>Grade 3 or Grade 4</strong></p><p><strong>(%)</strong></p></td></tr></thead><tbody><tr><td colspan="5" style="vertical-align:top"><p><strong>Hematology</strong></p></td></tr><tr><td style="vertical-align:top"><p>Lymphopenia</p></td><td style="vertical-align:top"><p>63</p></td><td style="vertical-align:top"><p>6</p></td><td style="vertical-align:top"><p>36</p></td><td style="vertical-align:top"><p>4.2</p></td></tr><tr><td style="vertical-align:top"><p>Anemia</p></td><td style="vertical-align:top"><p>59</p></td><td style="vertical-align:top"><p>0.7</p></td><td style="vertical-align:top"><p>47</p></td><td style="vertical-align:top"><p>0.4</p></td></tr><tr><td style="vertical-align:top"><p>Thrombocytopenia</p></td><td style="vertical-align:top"><p>51</p></td><td style="vertical-align:top"><p>0.7</p></td><td style="vertical-align:top"><p>12</p></td><td style="vertical-align:top"><p>0.4</p></td></tr><tr><td style="vertical-align:top"><p>Neutropenia</p></td><td style="vertical-align:top"><p>41</p></td><td style="vertical-align:top"><p>3</p></td><td style="vertical-align:top"><p>10</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Chemistry</strong></p></td></tr><tr><td style="vertical-align:top"><p>Hyperglycemia<sup>&Dagger;</sup></p></td><td style="vertical-align:top"><p>37</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>31</p></td><td style="vertical-align:top"><p>0.5</p></td></tr><tr><td style="vertical-align:top"><p>Hypermagnesemia</p></td><td style="vertical-align:top"><p>30</p></td><td style="vertical-align:top"><p>0.7</p></td><td style="vertical-align:top"><p>11</p></td><td style="vertical-align:top"><p>0.4</p></td></tr><tr><td style="vertical-align:top"><p>Hyponatremia</p></td><td style="vertical-align:top"><p>26</p></td><td style="vertical-align:top"><p>1.1</p></td><td style="vertical-align:top"><p>27</p></td><td style="vertical-align:top"><p>1.5</p></td></tr><tr><td style="vertical-align:top"><p>Increased AST</p></td><td style="vertical-align:top"><p>22</p></td><td style="vertical-align:top"><p>1.1</p></td><td style="vertical-align:top"><p>43</p></td><td style="vertical-align:top"><p>4.1</p></td></tr><tr><td style="vertical-align:top"><p>Increased ALT</p></td><td style="vertical-align:top"><p>21</p></td><td style="vertical-align:top"><p>0.7</p></td><td style="vertical-align:top"><p>52</p></td><td style="vertical-align:top"><p>8</p></td></tr><tr><td style="vertical-align:top"><p>Hypokalemia</p></td><td style="vertical-align:top"><p>16</p></td><td style="vertical-align:top"><p>0.4</p></td><td style="vertical-align:top"><p>22</p></td><td style="vertical-align:top"><p>1.1</p></td></tr><tr><td style="vertical-align:top"><p>Hyperbilirubinemia</p></td><td style="vertical-align:top"><p>14</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>29</p></td><td style="vertical-align:top"><p>1.1</p></td></tr></tbody></table><p><sup>*</sup>NCI CTCAE v4.0</p><p><sup>&dagger;</sup>Each test incidence, except for hyperglycemia, is based on the number of patients who had both baseline and at least one on-study laboratory measurement available (TAGRISSO range: 267 - 273 and EGFR TKI comparator range: 256 - 268).</p><p><sup>&Dagger;</sup>Hyperglycemia<sup> </sup>is based on the number of patients who had both baseline and at least one on-study laboratory measurement available: TAGRISSO (179) and EGFR comparator (191).</p><p>&nbsp;</p><p>Clinically relevant laboratory abnormalities in FLAURA that occurred in &lt;20% of patients receiving TAGRISSO was increased blood creatinine (9%).</p><p><u>&nbsp;</u></p><p><u>Previously Untreated EGFR Mutation-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer &ndash; TAGRISSO in Combination with Pemetrexed and Platinum-based Chemotherapy</u></p><p><u>&nbsp;</u></p><p>The safety of TAGRISSO in combination with pemetrexed and platinum-based chemotherapy was evaluated in FLAURA2, a multicenter international open-label, randomized (1:1), active-controlled trial conducted in 557 patients with EGFR exon 19 deletion or exon 21 L858R mutation-positive, locally advanced or metastatic NSCLC who had not received previous systemic treatment for advanced disease. The median duration of exposure to TAGRISSO in combination with pemetrexed and platinum-based chemotherapy was 22.3 months and the median duration of exposure to TAGRISSO monotherapy was 19.3&nbsp;months.</p><p>Serious adverse reactions were reported in 38% of patients treated with TAGRISSO in combination with pemetrexed and platinum-based chemotherapy; the most frequently reported serious adverse reactions (&ge;2%) in the combination arm were anemia (3.3%), COVID-19 (2.5%), pneumonia (2.5%), febrile neutropenia (2.2%), thrombocytopenia (2.2%), and pulmonary embolism (2.2%). Fatal adverse reactions occurred in 7% of patients who received TAGRISSO in combination with pemetrexed and platinum-based chemotherapy including pulmonary embolism (1.1%), pneumonia (1.1%) and cardiomyopathy (1.1%).</p><p>Dosage interruptions of TAGRISSO, when given with pemetrexed and platinum-based chemotherapy, due to an adverse reaction occurred in 44% of patients. Adverse reactions which required dosage interruption in &ge; 2% of patients included anemia (4.7%), neutropenia (4.3%), diarrhea (3.6%), febrile neutropenia (3.3%) and thrombocytopenia (2.9%).</p><p>Permanent discontinuation of TAGRISSO when given in combination with pemetrexed and platinum-based chemotherapy due to an adverse reaction occurred in 11% of patients. Adverse reactions which resulted in permanent discontinuation of TAGRISSO in &ge;1% of patients included ILD/pneumonitis (2.9%), pneumonia (1.4%), and decreased ejection fraction (1.1%).</p><p>Adverse reactions leading to dose reduction of TAGRISSO occurred in 10% of patients treated with TAGRISSO in combination with pemetrexed and platinum-based chemotherapy. The most frequently reported adverse reactions leading to dose reduction of TAGRISSO in the combination arm in &ge;1% of patients were diarrhea (1.1%) and rash (1.1%).</p><p>Tables 9 and 10 summarize common adverse reactions and laboratory abnormalities which occurred in FLAURA2.</p><p>Table 9. Adverse Reactions (<strong>numbers in the table are adverse events with no causality established to the Investigational Medicinal Product)</strong> Occurring in &ge;10% of Patients Receiving TAGRISSO in FLAURA2*</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><thead><tr><td rowspan="2"><p><strong>Adverse Reaction</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>TAGRISSO with Pemetrexed and Platinum-based Chemotherapy (N=276)</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>TAGRISSO</strong></p><p><strong>(N=275)</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Any Grade (%)</strong></p></td><td style="vertical-align:top"><p><strong>Grade 3 or higher</strong></p><p><strong>(%)</strong></p></td><td style="vertical-align:top"><p><strong>Any Grade (%)</strong></p></td><td style="vertical-align:top"><p><strong>Grade 3 or higher</strong></p><p><strong>(%)</strong></p></td></tr></thead><tbody><tr><td colspan="5" style="vertical-align:top"><p><strong>Gastrointestinal Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Diarrhea</p></td><td style="vertical-align:top"><p>43</p></td><td style="vertical-align:top"><p>2.9</p></td><td style="vertical-align:top"><p>41</p></td><td style="vertical-align:top"><p>0.4</p></td></tr><tr><td style="vertical-align:top"><p>Stomatitis<strong><sup>&dagger;</sup></strong></p></td><td style="vertical-align:top"><p>31</p></td><td style="vertical-align:top"><p>0.4</p></td><td style="vertical-align:top"><p>21</p></td><td style="vertical-align:top"><p>0.4</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Skin Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rash<sup>&Dagger; </sup></p></td><td style="vertical-align:top"><p>49</p></td><td style="vertical-align:top"><p>2.5</p></td><td style="vertical-align:top"><p>44</p></td><td style="vertical-align:top"><p>1.5</p></td></tr><tr><td style="vertical-align:top"><p>Nail toxicity<sup>&para;</sup></p></td><td style="vertical-align:top"><p>27</p></td><td style="vertical-align:top"><p>0.7</p></td><td style="vertical-align:top"><p>32</p></td><td style="vertical-align:top"><p>0.4</p></td></tr><tr><td style="vertical-align:top"><p>Dry skin<sup>&sect; </sup></p></td><td style="vertical-align:top"><p>24</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>31</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p>Pruritus<sup>#</sup></p></td><td style="vertical-align:top"><p>8</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>11</p></td><td style="vertical-align:top"><p>0</p></td></tr></tbody></table><p><sup>*</sup>NCI CTCAE v5.0</p><p><strong><sup>&dagger;</sup></strong>Includes stomatitis and mouth ulceration.</p><p><sup>&Dagger;</sup>Includes rash, rash erythematous, rash macular, rash maculo-papular, rash papular, rash pustular, rash pruritic, rash vesicular, rash follicular, erythema, folliculitis, acne, dermatitis, dermatitis acneiform, drug eruption, skin erosion, pustule.</p><p><sup>&para;</sup>Includes nail bed disorder, nail bed inflammation, nail bed infection, nail discoloration, nail pigmentation, nail disorder, nail toxicity, nail dystrophy, nail infection, nail ridging, onychalgia, onychoclasis, onycholysis, onychomadesis, onychomalacia, paronychia.</p><p><sup>&sect;</sup>Includes dry skin, skin fissures, xerosis, eczema, xeroderma.</p><p><sup>#</sup>Includes pruritus, eyelid pruritus.</p><p>&nbsp;</p><p>Clinically relevant adverse reactions in FLAURA2 in &lt;10% of patients receiving TAGRISSO in combination with pemetrexed and platinum-based chemotherapy were alopecia (9%), epistaxis (7%), palmar-plantar erythrodysesthesia syndrome (5%), interstitial lung disease (3.3%) skin hyperpigmentation (2.5%), , QTc interval prolongation (1.8%), erythema multiforme (1.4%), urticaria (1.4%), and keratitis (0.7%). QTc interval prolongation represents the incidence of patients who had a QTcF prolongation &gt;500 msec.</p><p>&nbsp;</p><p>Table 10. Laboratory Abnormalities Worsening from Baseline in &ge;20% of Patients in FLAURA2*<sup>,&dagger;</sup></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><thead><tr><td rowspan="2"><p><strong>Laboratory Abnormality</strong><sup>&Dagger;</sup></p></td><td colspan="2" style="vertical-align:top"><p><strong>TAGRISSO with Pemetrexed and Platinum-based Chemotherapy (N=276)</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>TAGRISSO</strong></p><p><strong>(N=275)</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>All Grades (%)</strong></p></td><td style="vertical-align:top"><p><strong>Grade 3 or Grade 4</strong></p><p><strong>(%)</strong></p></td><td style="vertical-align:top"><p><strong>All Grades</strong></p><p><strong>(%)</strong></p></td><td style="vertical-align:top"><p><strong>Grade 3 or Grade 4</strong></p><p><strong>(%)</strong></p></td></tr></thead><tbody><tr><td colspan="5" style="vertical-align:top"><p><strong>Hematology</strong></p></td></tr><tr><td style="vertical-align:top"><p>Leukopenia</p></td><td style="vertical-align:top"><p>88</p></td><td style="vertical-align:top"><p>20</p></td><td style="vertical-align:top"><p>53</p></td><td style="vertical-align:top"><p>3.3</p></td></tr><tr><td style="vertical-align:top"><p>Thrombocytopenia</p></td><td style="vertical-align:top"><p>85</p></td><td style="vertical-align:top"><p>16</p></td><td style="vertical-align:top"><p>44</p></td><td style="vertical-align:top"><p>1.8</p></td></tr><tr><td style="vertical-align:top"><p>Neutropenia</p></td><td style="vertical-align:top"><p>85</p></td><td style="vertical-align:top"><p>36</p></td><td style="vertical-align:top"><p>40</p></td><td style="vertical-align:top"><p>4.7</p></td></tr><tr><td style="vertical-align:top"><p>Lymphopenia</p></td><td style="vertical-align:top"><p>78</p></td><td style="vertical-align:top"><p>16</p></td><td style="vertical-align:top"><p>55</p></td><td style="vertical-align:top"><p>7</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Chemistry</strong></p></td></tr><tr><td><p>Blood creatinine increased</p></td><td style="vertical-align:top"><p>22</p></td><td style="vertical-align:top"><p>0.4</p></td><td style="vertical-align:top"><p>8</p></td><td style="vertical-align:top"><p>0</p></td></tr></tbody></table><p><sup>*</sup>NCI CTCAE v5.0</p><p><strong><sup>&dagger;</sup></strong>Findings based on test results presented as CTCAE grade shifts.</p><p><sup>&Dagger;</sup>Each test incidence is based on the number of patients who had both baseline and at least one on-study laboratory measurement available (TAGRISSO with pemetrexed and platinum-based chemotherapy arm: 275 and TAGRISSO monotherapy arm: 275).</p><p><strong><u>Previously Treated EGFR T790M Mutation-Positive Metastatic Non-Small Cell Lung Cancer &ndash; Monotherapy</u></strong></p><p>The safety of TAGRISSO was evaluated in AURA3, a multicenter international open label randomized (2:1) controlled trial conducted in 419 patients with unresectable or metastatic EGFR T790M mutation-positive NSCLC who had progressive disease following first line EGFR TKI treatment. A total of 279 patients received TAGRISSO 80&nbsp;mg orally once daily until intolerance to therapy, disease progression, or investigator determination that the patient was no longer benefiting from treatment. A total of 136 patients received pemetrexed plus either carboplatin or cisplatin every three weeks for up to 6 cycles; patients without disease progression after 4 cycles of chemotherapy could continue maintenance pemetrexed until disease progression, unacceptable toxicity, or investigator determination that the patient was no longer benefiting from treatment. Left Ventricular Ejection Fraction (LVEF) was evaluated at screening and every 12 weeks. The median duration of treatment was 8.1 months for patients treated with TAGRISSO and 4.2 months for chemotherapy-treated patients. The trial population characteristics were: median age 62 years, age less than 65 (58%), female (64%), Asian (65%), never smokers (68%), and ECOG PS 0 or 1 (100%).</p><p>Serious adverse reactions were reported in 18% of patients treated with TAGRISSO and 26% in the chemotherapy group. No single serious adverse reaction was reported in 2% or more patients treated with TAGRISSO. One patient (0.4%) treated with TAGRISSO experienced a fatal adverse reaction (ILD/pneumonitis).</p><p>Dose reductions occurred in 2.9% of patients treated with TAGRISSO. The most frequent adverse reactions leading to dose reductions or interruptions were prolongation of the QT interval as assessed by ECG (1.8%), neutropenia (1.1%), and diarrhea (1.1%). Adverse reactions resulting in permanent discontinuation of TAGRISSO occurred in 7% of patients treated with TAGRISSO. The most frequent adverse reaction leading to discontinuation of TAGRISSO was ILD/pneumonitis (3%).</p><p>Tables 11 and 12 summarize common adverse reactions and laboratory abnormalities which occurred in TAGRISSO-treated patients in AURA3.</p><p>Table 11. Adverse Reactions (<strong>Numbers in the table are adverse events with no causality established to the Investigational Medicinal Product)</strong> Occurring in &ge;10% of Patients Receiving TAGRISSO in AURA3<sup>*</sup></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><thead><tr><td rowspan="2"><p><strong>Adverse Reaction</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>TAGRISSO<br />(N=279)</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>Chemotherapy (Pemetrexed/Cisplatin or Pemetrexed/Carboplatin)</strong></p><p><strong>(N=136)</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>All Grades</strong><sup>&dagger;</sup></p><p><strong>(%)</strong></p></td><td style="vertical-align:top"><p><strong>Grade 3/4</strong><sup>&dagger;</sup></p><p><strong>(%)</strong></p></td><td style="vertical-align:top"><p><strong>All Grades</strong><sup>&dagger;</sup></p><p><strong>(%)</strong></p></td><td style="vertical-align:top"><p><strong>Grade 3/4</strong><sup>&dagger;</sup></p><p><strong>(%)</strong></p></td></tr></thead><tbody><tr><td colspan="5" style="vertical-align:top"><p><strong>Gastrointestinal Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Diarrhea</p></td><td style="vertical-align:top"><p>41</p></td><td style="vertical-align:top"><p>1.1</p></td><td style="vertical-align:top"><p>11</p></td><td style="vertical-align:top"><p>1.5</p></td></tr><tr><td style="vertical-align:bottom"><p>Nausea</p></td><td style="vertical-align:top"><p>16</p></td><td style="vertical-align:top"><p>0.7</p></td><td style="vertical-align:top"><p>49</p></td><td style="vertical-align:top"><p>3.7</p></td></tr><tr><td style="vertical-align:bottom"><p>Stomatitis<sup>‖</sup></p></td><td style="vertical-align:top"><p>19</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>15</p></td><td style="vertical-align:top"><p>1.5</p></td></tr><tr><td style="vertical-align:bottom"><p>Constipation</p></td><td style="vertical-align:top"><p>14</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>35</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:bottom"><p>Vomiting</p></td><td style="vertical-align:top"><p>11</p></td><td style="vertical-align:top"><p>0.4</p></td><td style="vertical-align:top"><p>20</p></td><td style="vertical-align:top"><p>2.2</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Skin Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rash<sup>&Dagger;</sup></p></td><td style="vertical-align:top"><p>34</p></td><td style="vertical-align:top"><p>0.7</p></td><td style="vertical-align:top"><p>6</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p>Dry skin<sup>&sect;</sup></p></td><td style="vertical-align:top"><p>23</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>4.4</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p>Nail toxicity<sup>&para;</sup></p></td><td style="vertical-align:top"><p>22</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>1.5</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td style="vertical-align:top"><p>Pruritus<sup>#</sup></p></td><td style="vertical-align:top"><p>13</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>5</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>General Disorders and Administration Site Conditions</strong></p></td></tr><tr><td style="vertical-align:top"><p>Fatigue<sup>&thorn;</sup></p></td><td style="vertical-align:top"><p>22</p></td><td style="vertical-align:top"><p>1.8</p></td><td style="vertical-align:top"><p>40</p></td><td style="vertical-align:top"><p>5.1</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Metabolism and Nutrition Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Decreased appetite</p></td><td style="vertical-align:top"><p>18</p></td><td style="vertical-align:top"><p>1.1</p></td><td style="vertical-align:top"><p>36</p></td><td style="vertical-align:top"><p>2.9</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Respiratory, Thoracic and Mediastinal Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Cough</p></td><td style="vertical-align:top"><p>17</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>14</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Musculoskeletal and Connective Tissue Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Back pain</p></td><td style="vertical-align:top"><p>10</p></td><td style="vertical-align:top"><p>0.4</p></td><td style="vertical-align:top"><p>9</p></td><td style="vertical-align:top"><p>0.7</p></td></tr></tbody></table><p><sup>*</sup>NCI CTCAE v4.0.</p><p><sup>&dagger;</sup>No grade 4 events were reported.</p><p><sup>‖</sup>Includes stomatitis and mouth ulceration.</p><p><sup>&Dagger;</sup>Includes rash, rash generalized, rash erythematous, rash macular, rash maculo-papular, rash papular, rash pustular, erythema, folliculitis, acne, dermatitis, acneiform dermatitis, pustule.</p><p><sup>&sect;</sup><sup> </sup>Includes dry skin, eczema, skin fissures, xerosis.</p><p><sup>&para;</sup>Includes nail disorders, nail bed disorders, nail bed inflammation, nail bed tenderness, nail discoloration, nail disorder, nail dystrophy, nail infection, nail ridging, nail toxicity, onychalgia, onychoclasis, onycholysis, onychomadesis, paronychia.</p><p><sup>#</sup>Includes pruritus, pruritus generalized, eyelid pruritus.</p><p><sup>&thorn;</sup>Includes fatigue, asthenia.</p><p>&nbsp;</p><p>Clinically relevant adverse reactions in AURA3 in &lt;10% of patients receiving TAGRISSO were epistaxis (5%), interstitial lung disease (3.9%), alopecia (3.6%), urticaria (2.9%), palmar-plantar erythrodysesthesia syndrome (1.8%), QTc interval prolongation (1.4%), keratitis (1.1%),erythema multiforme (0.7%) and skin hyperpigmentation (0.4%). QTc interval prolongation represents the incidence of patients who had a QTcF prolongation &gt;500 msec.</p><p>&nbsp;</p><p>Table 12. Laboratory Abnormalities Worsening from Baseline in &ge;20% of Patients in AURA3</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><thead><tr><td rowspan="2"><p><strong>Laboratory Abnormality<sup>*, &dagger;</sup></strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>TAGRISSO</strong></p><p><strong>(N=279)</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>Chemotherapy (Pemetrexed/Cisplatin or Pemetrexed/Carboplatin)</strong></p><p><strong>(N=131)</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>All Grades (%)</strong></p></td><td style="vertical-align:top"><p><strong>Grade 3 or Grade 4 (%)</strong></p></td><td style="vertical-align:top"><p><strong>All Grades</strong></p><p><strong>(%)</strong></p></td><td style="vertical-align:top"><p><strong>Grade 3 or Grade 4</strong></p><p><strong>(%)</strong></p></td></tr></thead><tbody><tr><td colspan="5" style="vertical-align:top"><p><strong>Hematology</strong></p></td></tr><tr><td style="vertical-align:top"><p>Anemia</p></td><td style="vertical-align:top"><p>43</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>79</p></td><td style="vertical-align:top"><p>3.1</p></td></tr><tr><td style="vertical-align:top"><p>Lymphopenia</p></td><td style="vertical-align:top"><p>63</p></td><td style="vertical-align:top"><p>8</p></td><td style="vertical-align:top"><p>61</p></td><td style="vertical-align:top"><p>10</p></td></tr><tr><td style="vertical-align:top"><p>Thrombocytopenia</p></td><td style="vertical-align:top"><p>46</p></td><td style="vertical-align:top"><p>0.7</p></td><td style="vertical-align:top"><p>48</p></td><td style="vertical-align:top"><p>7</p></td></tr><tr><td style="vertical-align:top"><p>Neutropenia</p></td><td style="vertical-align:top"><p>27</p></td><td style="vertical-align:top"><p>2.2</p></td><td style="vertical-align:top"><p>49</p></td><td style="vertical-align:top"><p>12</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Chemistry</strong></p></td></tr><tr><td style="vertical-align:top"><p>Hypermagnesemia<sup>&dagger;</sup></p></td><td style="vertical-align:top"><p>27</p></td><td style="vertical-align:top"><p>1.8</p></td><td style="vertical-align:top"><p>9</p></td><td style="vertical-align:top"><p>1.5</p></td></tr><tr><td style="vertical-align:top"><p>Hyponatremia<sup>&dagger;</sup></p></td><td style="vertical-align:top"><p>26</p></td><td style="vertical-align:top"><p>2.2</p></td><td style="vertical-align:top"><p>36</p></td><td style="vertical-align:top"><p>1.5</p></td></tr><tr><td style="vertical-align:top"><p>Hyperglycemia<sup>&Dagger;</sup></p></td><td style="vertical-align:top"><p>20</p></td><td style="vertical-align:top"><p>0</p></td><td style="vertical-align:top"><p>NA</p></td><td style="vertical-align:top"><p>NA</p></td></tr><tr><td style="vertical-align:top"><p>Hypokalemia<sup>&dagger;</sup></p></td><td style="vertical-align:top"><p>9</p></td><td style="vertical-align:top"><p>1.4</p></td><td style="vertical-align:top"><p>18</p></td><td style="vertical-align:top"><p>1.5</p></td></tr></tbody></table><p>NA=not applicable</p><p><sup>*</sup>NCI CTCAE v4.0</p><p><sup>&dagger;</sup>Each test incidence, except for hyperglycemia, is based on the number of patients who had both baseline and at least one on-study laboratory measurement available (TAGRISSO 279, Chemotherapy comparator 131)</p><p><sup>&Dagger;</sup>Hyperglycemia<sup> </sup>is based on the number of patients who had both baseline and at least one on-study laboratory measurement available (TAGRISSO 270, Chemotherapy 5; fasting glucose was not a protocol requirement for patients in the chemotherapy arm)</p><p>&nbsp;</p><p>Clinically relevant laboratory abnormalities in AURA3 that occurred in &lt;20% of patients receiving TAGRISSO included increased blood creatinine (7%).</p><p><u>Other Clinical Trials Experience</u></p><p>&nbsp;</p><p>The following adverse reaction has been reported following administration of TAGRISSO: increased blood creatine phosphokinase.</p><p>&nbsp;</p><p>Post marketing Experience<!--[if supportFields]><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_d1dc99b1-6194-4af7-8963-33d5f8ff3677 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>&nbsp;</p><p>The following adverse reactions have been identified during post-approval use of TAGRISSO. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Skin and subcutaneous tissue: </em>Erythema multiforme major (EMM), Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN),<em> </em>cutaneous vasculitis, erythema dyschromicum perstans</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <em>Blood and lymphatic system disorders:</em> Aplastic anemia</p><p><em>&nbsp;</em></p><p>To report any side effect(s):</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong><em>Saudi Arabia: </em></strong></p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p><p><strong>- </strong>The National Pharmacovigilance Centre (NPC)</p><ul><li>Toll free phone: 19999</li><li>E-mail: npc.drug@sfda.gov.sa&nbsp;&nbsp;</li><li>Website: https://ade.sfda.gov.sa/</li></ul><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other GCC States:</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Please contact the relevant competent authority.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In TAGRISSO clinical studies a limited number of patients were treated with daily doses of up to 240 mg without dose limiting toxicities. In these studies, patients who were treated with TAGRISSO daily doses of 160 mg and 240 mg experienced an increase in the frequency and severity of a number of typical EGFR TKI-induced AEs (primarily diarrhoea and skin rash) compared to the 80 mg dose. There is limited experience with accidental overdoses in humans. All cases were isolated incidents of patients taking an additional daily dose of TAGRISSO in error, without any resulting clinical consequences.</p><p>&nbsp;</p><p>There is no specific treatment in the event of TAGRISSO overdose. In case of suspected overdose, TAGRISSO should be withheld and symptomatic treatment initiated.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: antineoplastic agents, protein kinase inhibitors; ATC code: L01EB04. <u>Mechanism of action</u></p><p>Osimertinib is a Tyrosine Kinase Inhibitor (TKI). It is an irreversible inhibitor of EGFRs harboring sensitising-mutations (EGFRm) and TKI-resistance mutation T790M.</p><p><u>Pharmacodynamic effects</u></p><p>&nbsp;</p><p><em>In vitro </em>studies have demonstrated that osimertinib has high potency and inhibitory activity against EGFR across a range of all clinically relevant EGFR sensitising-mutant and T790M mutant NSCLC cell lines (apparent IC50s from 6 nM to 54 nM against phospho-EGFR). This leads to inhibition of cell growth, while showing significantly less activity against EGFR in wild-type cell lines (apparent IC50s from 480 nM to 1.8 &mu;M against phospho-EGFR). <em>In vivo </em>oral administration of osimertinib lead to tumour shrinkage in both EGFRm and T790M NSCLC xenograft and transgenic mouse lung tumour models.</p><p>&nbsp;</p><p><em><u>Cardiac electrophysiology</u></em></p><p>The QTc interval prolongation potential of TAGRISSO was assessed in 210 patients who received osimertinib 80 mg daily in AURA2. Serial ECGs were collected following a single dose and at steady- state to evaluate the effect of osimertinib on QTc intervals. A pharmacokinetic/pharmacodynamic analysis predicted a drug-related QTc interval prolongation at 80 mg of 14 msec with an upper bound of 16 msec (90% CI).</p><p>&nbsp;</p><p><u>Clinical efficacy and safety</u></p><p>&nbsp;</p><p>Adjuvant Treatment of Early-Stage EGFR Mutation-Positive Non-Small Cell Lung Cancer (NSCLC)<!--[if supportFields]><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_2ad2b633-e5bf-4b88-8d78-87aa984c06b4 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>&nbsp;</p><p>The efficacy of TAGRISSO was demonstrated in a randomized, double-blind, placebo-controlled trial (ADAURA [NCT02511106]) for the adjuvant treatment of patients with EGFR exon 19 deletions or exon 21 L858R mutation-positive NSCLC who had complete tumor resection, with or without prior adjuvant chemotherapy. Eligible patients with resectable tumors (stage IB &ndash; IIIA according to American Joint Commission on Cancer [AJCC] 7<sup>th</sup> edition) were required to have predominantly non-squamous histology and EGFR exon 19 deletions or exon 21 L858R mutations identified prospectively from tumor tissue in a central laboratory by the cobas<sup>&reg;</sup> EGFR Mutation Test. Patients with clinically significant uncontrolled cardiac disease, prior history of ILD/pneumonitis, or who received treatment with any EGFR kinase inhibitor were not eligible for the study.</p><p>Patients were randomized (1:1) to receive TAGRISSO 80 mg orally once daily or placebo following recovery from surgery and standard adjuvant chemotherapy if given. Patients who did not receive adjuvant chemotherapy were randomized within 10 weeks and patients who received adjuvant chemotherapy were randomized within 26 weeks following surgery. Randomization was stratified by mutation type (exon 19 deletions or exon 21 L858R mutations), race (Asian or non-Asian) and pTNM staging (IB or II or IIIA) according to AJCC 7<sup>th</sup> edition. Treatment was given for 3 years or until disease recurrence, or unacceptable toxicity.</p><p>The major efficacy outcome measure was disease-free survival (DFS, defined as reduction in the risk of disease recurrence or death) in patients with stage II &ndash; IIIA NSCLC determined by investigator assessment. Additional efficacy outcome measures included DFS in the overall population (patients with stage IB &ndash; IIIA NSCLC), and overall survival (OS) in patients with stage II &ndash; IIIA NSCLC and in the overall population.</p><p>A total of 682 patients were randomized to TAGRISSO (n=339) or placebo (n=343). The median age was 63 years (range 30-86 years); 70% were female; 64% were Asian and 72% were never smokers. Baseline World Health Organization (WHO) performance status was 0 (64%) or 1 (36%); 31% had stage IB, 35% II, and 34%&nbsp;IIIA. With regard to EGFR mutation status, 55% were exon 19 deletions and 45% were exon 21 L858R mutations. The majority (60%) of patients received adjuvant chemotherapy prior to randomization (27% IB; 70% II, 79%&nbsp;IIIA).</p><p>ADAURA demonstrated a statistically significant difference in DFS for patients treated with TAGRISSO compared to patients treated with placebo. The final analysis of OS demonstrated a statistically significant improvement in OS for patients treated with TAGRISSO compared to patients treated with placebo. Median OS was not reached in either arm. In the overall population (IB-IIIA), the median follow-up time was 61.5 months in both treatment arms. Efficacy results from ADAURA are summarized in Table 13 and Figures 1 and 2, respectively.</p><p>Table 13. Efficacy Results in ADAURA according to Investigator Assessment</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td><td colspan="2"><p><strong>STAGE II-IIIA POPULATION</strong></p></td><td colspan="2"><p><strong>STAGE IB-IIIA POPULATION</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Efficacy Parameter</strong></p></td><td><p><strong>TAGRISSO</strong><br /><strong>(N=233)</strong></p></td><td><p><strong>PLACEBO</strong><br /><strong>(N=237)</strong></p></td><td><p><strong>TAGRISSO</strong><br /><strong>(N=339)</strong></p></td><td><p><strong>PLACEBO</strong><br /><strong>(N=343)</strong></p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Disease-Free Survival (DFS)</strong></p></td></tr><tr><td style="vertical-align:top"><p>DFS events (%)</p></td><td><p>26 (11)</p></td><td><p>130 (55)</p></td><td><p>37 (11)</p></td><td><p>159 (46)</p></td></tr><tr><td style="vertical-align:top"><p>Recurrent disease (%)</p></td><td><p>26 (11)</p></td><td><p>129 (54)</p></td><td><p>37 (11)</p></td><td><p>157 (46)</p></td></tr><tr><td style="vertical-align:top"><p>Deaths (%)</p></td><td><p>0</p></td><td><p>1 (0.4)</p></td><td><p>0</p></td><td><p>2 (0.6)</p></td></tr><tr><td style="vertical-align:top"><p>Median DFS, months (95% CI)</p></td><td><p>NR (38.8, NE)</p></td><td><p>19.6 (16.6, 24.5)</p></td><td><p>NR (NE, NE)</p></td><td><p>27.5 (22.0, 35.0)</p></td></tr><tr><td style="vertical-align:top"><p>Hazard ratio (95% CI)<sup>&Dagger;,</sup><sup>&sect;</sup></p></td><td colspan="2"><p>0.17 (0.12, 0.23)</p></td><td colspan="2"><p>0.20 (0.15, 0.27)</p></td></tr><tr><td style="vertical-align:top"><p>p-value<sup>&Dagger;,</sup><sup>‖</sup></p></td><td colspan="2"><p>&lt;0.0001</p></td><td colspan="2"><p>&lt;0.0001</p></td></tr><tr><td colspan="5" style="vertical-align:top"><p><strong>Overall Survival (OS)</strong></p></td></tr><tr><td style="vertical-align:top"><p>Number of deaths (%)</p></td><td style="vertical-align:top"><p>35 (15)</p></td><td style="vertical-align:top"><p>65 (27)</p></td><td style="vertical-align:top"><p>42 (12)</p></td><td style="vertical-align:top"><p>82 (24)</p></td></tr><tr><td style="vertical-align:top"><p>Hazard Ratio (95% CI)<sup>&Dagger;,</sup><sup>&sect;</sup></p></td><td colspan="2" style="vertical-align:top"><p>0.49 (0.33, 0.73)</p></td><td colspan="2" style="vertical-align:top"><p>0.49 (0.34, 0.70)</p></td></tr><tr><td style="vertical-align:top"><p>p-value<sup>&Dagger;,</sup><sup>‖</sup></p></td><td colspan="2" style="vertical-align:top"><p>0.0004</p></td><td colspan="2" style="vertical-align:top"><p>&lt;0.0001</p></td></tr></tbody></table><p>DFS results based on investigator assessment.</p><p>CI=Confidence Interval; NE=Not Estimable; NR=Not Reached</p><p><sup>&Dagger;</sup>Stratified by race (Asian vs non-Asian), mutation status (Ex19del vs L858R), and pTNM staging</p><p><sup>&sect;</sup>Pike estimator</p><p><sup>‖</sup>Stratified log-rank test</p><p>&nbsp;</p><p>&nbsp;</p><p dir="ltr">Figure 1. Kaplan-Meier Curves of Disease-Free Survival (Overall Population) by Investigator Assessment in ADAURA</p><p dir="ltr"><img src="data:image/jpeg;base64,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" alt="" width="1300" height="847" vspace="0" hspace="0" border="0" style="width:1300px;height:847px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p dir="ltr">&nbsp;</p><p>Figure 2. Kaplan-Meier Curves of Overall Survival (Overall Population) in ADAURA</p><p><img src="data:image/jpeg;base64,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" alt="" width="1430" height="940" vspace="0" hspace="0" border="0" style="width:1430px;height:940px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p dir="ltr">&nbsp;</p><p>In an exploratory analysis of site(s) of relapse, the proportion of patients with CNS involvement at the time of disease recurrence was 5 patients (1.5%) on the TAGRISSO arm and 34 patients (10%) on the placebo arm.</p><p>&nbsp;</p><p>Locally Advanced, Unresectable (Stage III) EGFR Mutation Positive NSCLC<!--[if supportFields]><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_d49d0d77-a930-41ee-a31d-82d5883c65ce \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>The efficacy of TAGRISSO was evaluated in the LAURA trial [NCT03521154], a double blind, randomized, placebo-controlled study in adult patients with locally advanced, unresectable stage III NSCLC with EGFR exon 19 deletions or exon 21 L858R mutations whose disease had not progressed during or following definitive platinum-based chemoradiation therapy. Eligible patients were randomized within 42 days prior to study randomization and had a WHO performance status of 0 or 1. Prior to study enrollment, patients received concurrent chemoradiation therapy (cCRT) or sequential chemoradiation therapy (sCRT) regimens, where at least 2 cycles every 3 weeks or 5 doses of weekly platinum-based chemotherapy and definitive radiation were to be completed &le;6 weeks prior to randomization. The study excluded patients who had progressive disease during or following definitive chemoradiation therapy and patients with Grade &ge;2 pneumonitis after chemoradiation therapy or any ILD prior to chemoradiation therapy. Patient tumor tissue samples were required to have an EGFR exon 19 deletion or exon 21 L858R mutation, as identified by the cobas&reg; EGFR Mutation Test v2 in a central laboratory or by an FDA-approved test at a CLIA certified&nbsp; or accredited laboratory.</p><p>Patients were randomized (2:1) to receive either TAGRISSO 80 mg orally once daily or placebo until disease progression or unacceptable toxicity. Randomization was stratified by prior chemoradiation strategy (cCRT vs sCRT), tumor staging prior to chemoradiation (IIIA vs IIIB/IIIC), and by region (China versus rest of the world). Post progression, all patients were offered open label TAGRISSO if, in the opinion of the treating healthcare provider, there was an expected clinical benefit. Tumor assessments were performed every 8 weeks until week 48, and then every 12 weeks.</p><p>The major efficacy outcome measure was progression free survival (PFS) as assessed by blinded independent central review (BICR). Additional efficacy outcome measures included OS and CNS PFS.</p><p>A total of 216 patients were randomized (2:1) to TAGRISSO (n=143) or placebo (n=73). The study population characteristics were: median age 63 years (range 36-84 years); 13% &ge;75 years old; 61% female; 82% Asian, 14% White, 1.4% American Indian or Alaska Native and 2.3% had reported race as other; 6% were Hispanic or Latino; and 70% were never smokers. Baseline WHO performance status was 0 (51%) or 1 (49%); 35% of patients had stage IIIA, 49% of patients had stage IIIB and 16% of patients had stage IIIC NSCLC; 4% had squamous and 96% had non-squamous histology; 54% had exon 19 deletions and 45% had exon 21 L858R mutations. Prior to randomization, 89% of patients received cCRT and 11% of patients received sCRT. All patients received platinum-based chemotherapy (55% carboplatin-based chemotherapy and 44% cisplatin-based chemotherapy). The median total dose of radiation was 60 Gy for patients in both arms.</p><p>LAURA demonstrated a statistically significant improvement in PFS for patients randomized to TAGRISSO as compared to placebo. Efficacy results from LAURA are summarized in Table 14, and the Kaplan-Meier curve for PFS is shown in Figure 3. While OS results were immature at the current analysis, with 36% of pre-specified deaths for the final analysis reported, no trend towards a detriment was observed.</p><p>&nbsp;</p><p>Table 14. Efficacy Results in LAURA</p><table border="1" cellspacing="0" cellpadding="0" style="width:614px"><thead><tr><td style="vertical-align:top"><p><strong>Efficacy Parameter</strong></p></td><td style="vertical-align:top"><p><strong>TAGRISSO</strong></p><p><strong>(N=143)</strong></p></td><td style="vertical-align:top"><p><strong>Placebo<br />(N=73)</strong></p></td></tr></thead><tbody><tr><td colspan="3"><p><strong>Progression-Free Survival</strong><!--[if supportFields]><b style='mso-bidi-font-weight:
  normal'><span style='mso-bidi-font-size:12.0pt'><span style='mso-element:
  field-begin'></span> DOCVARIABLE
  vault_nd_5b1de6f2-9315-4151-8906-df4ece24df27 \* MERGEFORMAT <span
  style='mso-element:field-separator'></span></span></b><![endif]--><strong>&nbsp;</strong><!--[if supportFields]><b
  style='mso-bidi-font-weight:normal'><span style='mso-bidi-font-size:12.0pt'><span
  style='mso-element:field-end'></span></span></b><![endif]--></p></td></tr><tr><td><p>PFS events (%)</p></td><td><p>57 (40)</p></td><td><p>63 (86)<!--[if supportFields]><span
  style='mso-element:field-begin'></span>DOCVARIABLE
  VAULT_ND_f5831e5a-6ea9-45d8-a0c5-ed44bcc14c45 \* MERGEFORMAT<span
  style='mso-element:field-separator'></span><![endif]--> <!--[if supportFields]><span
  style='mso-element:field-end'></span><![endif]--></p></td></tr><tr><td><p>Progressive disease (%)</p></td><td><p>53 (37)</p></td><td><p>62 (85)<!--[if supportFields]><span
  style='mso-element:field-begin'></span>DOCVARIABLE VAULT_ND_913bb0ea-d38d-4d48-931c-17a22d4cc178
  \* MERGEFORMAT<span style='mso-element:field-separator'></span><![endif]--> <!--[if supportFields]><span
  style='mso-element:field-end'></span><![endif]--></p></td></tr><tr><td><p>Death<sup>*</sup> (%)</p></td><td><p>4 (3)</p></td><td><p>1 (1)<!--[if supportFields]><span
  style='mso-element:field-begin'></span>DOCVARIABLE
  VAULT_ND_596e28d0-343f-46d7-b27f-60b8e2a1e8ed \* MERGEFORMAT<span
  style='mso-element:field-separator'></span><![endif]--> <!--[if supportFields]><span
  style='mso-element:field-end'></span><![endif]--></p></td></tr><tr><td><p>Median PFS in months (95% CI)</p></td><td><p>39.1 (31.5, NE)<!--[if supportFields]><span
  style='mso-element:field-begin'></span>DOCVARIABLE VAULT_ND_6adec7bb-3d4e-4ce6-8f28-ce5988021301
  \* MERGEFORMAT<span style='mso-element:field-separator'></span><![endif]--> <!--[if supportFields]><span
  style='mso-element:field-end'></span><![endif]--></p></td><td><p>5.6 (3.7, 7.4)<!--[if supportFields]><span
  style='mso-element:field-begin'></span>DOCVARIABLE
  VAULT_ND_2b52dffc-1d86-437c-ab23-7501eac02481 \* MERGEFORMAT<span
  style='mso-element:field-separator'></span><![endif]--> <!--[if supportFields]><span
  style='mso-element:field-end'></span><![endif]--></p></td></tr><tr><td><p>Hazard Ratio (95% CI)<sup>&dagger;,&Dagger;</sup><!--[if supportFields]><sup><span
  style='mso-element:field-begin'></span> DOCVARIABLE
  vault_nd_b98dfb45-9133-4ec3-a205-f75ef18a4a02 \* MERGEFORMAT <span
  style='mso-element:field-separator'></span></sup><![endif]--><sup>&nbsp;</sup><!--[if supportFields]><sup><span
  style='mso-element:field-end'></span></sup><![endif]--></p></td><td colspan="2"><p>0.16 (0.10, 0.24)<!--[if supportFields]><span
  style='mso-element:field-begin'></span>DOCVARIABLE
  VAULT_ND_7487500e-b8b3-4941-9ba7-c5b38b9d4841 \* MERGEFORMAT<span
  style='mso-element:field-separator'></span><![endif]--> <!--[if supportFields]><span
  style='mso-element:field-end'></span><![endif]--></p></td></tr><tr><td><p>p-value<sup>&dagger;,&sect;</sup><!--[if supportFields]><sup><span
  style='mso-element:field-begin'></span> DOCVARIABLE
  vault_nd_1336b75e-dd7e-4d29-a55f-ed80bee4e048 \* MERGEFORMAT <span
  style='mso-element:field-separator'></span></sup><![endif]--><sup>&nbsp;</sup><!--[if supportFields]><sup><span
  style='mso-element:field-end'></span></sup><![endif]--></p></td><td colspan="2"><p>&lt;0.001<!--[if supportFields]><span
  style='mso-element:field-begin'></span>DOCVARIABLE
  VAULT_ND_ce1656b4-b404-4b3a-bf53-a71c3d73be38 \* MERGEFORMAT<span
  style='mso-element:field-separator'></span><![endif]--> <!--[if supportFields]><span
  style='mso-element:field-end'></span><![endif]--></p></td></tr><tr><td colspan="3"><p><strong>Overall Response Rate</strong><sup>&para;</sup><!--[if supportFields]><sup><span
  style='font-size:9.0pt'><span style='mso-element:field-begin'></span>
  DOCVARIABLE vault_nd_71329d5d-7e99-4508-8776-f6cd87c9d8df \* MERGEFORMAT <span
  style='mso-element:field-separator'></span></span></sup><![endif]--><sup>&nbsp;</sup><!--[if supportFields]><sup><span
  style='font-size:9.0pt'><span style='mso-element:field-end'></span></span></sup><![endif]--></p></td></tr><tr><td><p>ORR, % (95% CI)<!--[if supportFields]><span style='mso-element:field-begin'></span>DOCVARIABLE
  VAULT_ND_cb8de710-4cbc-4791-9eb9-cfffe449619f \* MERGEFORMAT<span
  style='mso-element:field-separator'></span><![endif]--> <!--[if supportFields]><span
  style='mso-element:field-end'></span><![endif]--></p></td><td><p>54 (45, 62)<!--[if supportFields]><span
  style='mso-element:field-begin'></span>DOCVARIABLE
  VAULT_ND_1fa020d2-8fe1-4d80-81c0-0431a75f9669 \* MERGEFORMAT<span
  style='mso-element:field-separator'></span><![endif]--> <!--[if supportFields]><span
  style='mso-element:field-end'></span><![endif]--></p></td><td><p>26 (17, 38)<!--[if supportFields]><span
  style='mso-element:field-begin'></span>DOCVARIABLE VAULT_ND_09001a8a-6488-4bd5-b890-5277ad3a3434
  \* MERGEFORMAT<span style='mso-element:field-separator'></span><![endif]--> <!--[if supportFields]><span
  style='mso-element:field-end'></span><![endif]--></p></td></tr></tbody></table><p>CI=Confidence Interval, NE=Not Estimable</p><p>PFS and ORR results as assessed by BICR.</p><p>*Without documented radiological disease progression.</p><p>&dagger;Stratified by disease stage prior to chemotherapy (IIIA vs IIIB/IIIC).</p><p>&Dagger;Pike estimator.</p><p>&sect;Stratified log-rank test.</p><p>&para;Confirmed responses.</p><p>&nbsp;</p><p>Figure 3. Kaplan-Meier Curves of PFS as assessed by BICR in LAURA</p><p><img src="data:image/jpeg;base64,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" alt="" width="1430" height="1036" vspace="0" hspace="0" border="0" style="width:1430px;height:1036px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p>All patients underwent magnetic resonance imaging (MRI) brain scans at baseline and at each follow-up during the study.&nbsp; In an exploratory analysis of site(s) of relapse, the proportion of patients with new CNS lesions at the time of disease progression was 17/143 patients (12%) on the TAGRISSO arm and 26/73 patients (36%) on the placebo arm.</p><p><s>&nbsp;</s></p><p>Previously Untreated EGFR Mutation-Positive Metastatic NSCLC<!--[if supportFields]><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_6f042a1c-a13e-4997-a849-5fb98f788406 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>FLAURA &ndash; TAGRISSO Monotherapy</p><p>The efficacy of TAGRISSO was demonstrated in a randomized, multicenter, double-blind, active-controlled trial (FLAURA [NCT02296125]) in patients with EGFR exon 19 deletions or exon 21 L858R mutation-positive, metastatic NSCLC, who had not received previous systemic treatment for metastatic disease. Patients were required to have measurable disease per RECIST v1.1, a WHO performance status of 0-1, and EGFR exon 19 deletions or exon 21 L858R mutation in tumor prospectively identified by the cobas<sup>&reg;</sup> EGFR Mutation Test in a central laboratory or by an investigational assay at a CLIA-certified or accredited laboratory. Patients with CNS metastases not requiring steroids and with stable neurologic status for at least two weeks after completion of definitive surgery or radiotherapy were eligible. Patients were assessed at the investigator&rsquo;s discretion for CNS metastases if they had a history of, or suspected, CNS metastases at study entry.</p><p>Patients were randomized (1:1) to receive TAGRISSO 80&nbsp;mg orally once daily or to receive gefitinib 250&nbsp;mg orally once daily or erlotinib 150&nbsp;mg orally once daily until disease progression or unacceptable toxicity. Randomization was stratified by EGFR mutation type (exon 19 deletions or exon 21 L858R mutation) and ethnicity (Asian or non-Asian). Patients randomized to the control arm were offered TAGRISSO at the time of disease progression if tumor samples tested positive for the EGFR T790M mutation. The major efficacy outcome measure was progression-free survival (PFS), as assessed by investigator. Additional efficacy outcome measures included OS and overall response rate (ORR).</p><p>&nbsp;</p><p>A total of 556 patients were randomized to TAGRISSO (n=279) or to control (gefitinib n=183; erlotinib n=94). The median age was 64 years (range 26-93 years); 54% were &lt;65 years of age; 63% were female; 62% were Asian and 64% were never smokers. Baseline WHO performance status was 0 (41%) or 1 (59%); 5% had Stage IIIb and 95% had Stage IV; and 7% received prior systemic cytotoxic chemotherapy as neoadjuvant or adjuvant therapy. With regard to EGFR tumor testing, 63% were exon 19 deletions and 37% were exon 21 L858R; 5 patients (&lt;1%) also had a concomitant de novo T790M mutation. EGFR mutation status was confirmed centrally using the cobas<sup>&reg;</sup> EGFR Mutation Test in 90% of patients. At the time of the final data cut-off, of those randomized to TAGRISSO and to investigator&rsquo;s choice erlotinib or gefitinib arm, 133 (48%) and 180 (65%) patients had received at least one subsequent treatment, respectively. Out of the 180 patients randomized to erlotinib or gefitinib who received subsequent treatment, 85 (47%) patients received TAGRISSO as first subsequent therapy.</p><p>&nbsp;</p><p>FLAURA demonstrated a statistically significant improvement in PFS for patients randomized to TAGRISSO as compared to erlotinib or gefitinib (see Table 12 and Figure 4). The final analysis of overall survival demonstrated a statistically significant improvement in overall survival in patients randomized to TAGRISSO compared to erlotinib or gefitinib (see Table 15 and Figure 5).</p><p>&nbsp;</p><p>Table 15. Efficacy Results in FLAURA according to Investigator Assessment</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><thead><tr><td style="vertical-align:top"><p><strong>Efficacy Parameter</strong></p></td><td style="vertical-align:top"><p><strong>TAGRISSO</strong></p><p><strong>(N=279)</strong></p></td><td style="vertical-align:top"><p><strong>EGFR TKI</strong></p><p><strong>(gefitinib or erlotinib)</strong></p><p><strong>(N=277)</strong></p></td></tr></thead><tbody><tr><td colspan="3"><p><strong>Progression-Free Survival (PFS)</strong></p></td></tr><tr><td><p>PFS events (%)</p></td><td><p>136 (49)</p></td><td><p>206 (74)</p></td></tr><tr><td><p>Progressive disease (%)</p></td><td><p>125 (45)</p></td><td><p>192 (69)</p></td></tr><tr><td><p>Death<sup>*</sup> (%)</p></td><td><p>11 (4)</p></td><td><p>14 (5)</p></td></tr><tr><td><p>Median PFS in months (95% CI)</p></td><td><p>18.9 (15.2, 21.4)</p></td><td><p>10.2 (9.6, 11.1)</p></td></tr><tr><td><p>Hazard Ratio (95% CI)<sup>&dagger;, &Dagger;</sup></p></td><td colspan="2"><p>0.46 (0.37, 0.57)</p></td></tr><tr><td><p>p-value<sup>&dagger;, &sect;</sup></p></td><td colspan="2"><p>&lt;0.0001</p></td></tr><tr><td colspan="3"><p><strong>Overall Survival (OS)</strong></p></td></tr><tr><td><p>Number of deaths (%)</p></td><td><p>155 (56)</p></td><td><p>166 (60)</p></td></tr><tr><td><p>Median OS in months (95% CI)</p></td><td><p>38.6 (34.5, 41.8)</p></td><td><p>31.8 (26.6, 36.0)</p></td></tr><tr><td><p>Hazard Ratio (95% CI)<sup>&dagger;, &Dagger;</sup></p></td><td colspan="2"><p>0.80 (0.64, 1.00)</p></td></tr><tr><td><p>p-value<sup>&dagger;, &sect;</sup></p></td><td colspan="2"><p>0.0462</p></td></tr><tr><td colspan="3"><p><strong>Overall Response Rate (ORR)</strong><sup>&para;</sup></p></td></tr><tr><td><p>ORR, % (95% CI)<sup>&dagger;</sup></p></td><td><p>77 (71, 82)</p></td><td><p>69 (63, 74)</p></td></tr><tr><td><p>Complete response, %</p></td><td><p>2</p></td><td><p>1</p></td></tr><tr><td><p>Partial response, %</p></td><td><p>75</p></td><td><p>68</p></td></tr><tr><td colspan="3"><p><strong>Duration of Response (DoR)</strong><sup>&para;</sup></p></td></tr><tr><td><p>Median in months (95% CI)</p></td><td><p>17.6 (13.8, 22.0)</p></td><td><p>9.6 (8.3, 11.1)</p></td></tr></tbody></table><p><sup>*</sup>Without documented radiological disease progression</p><p><sup>&dagger;</sup>Stratified by ethnicity (Asian vs non-Asian) and mutation status (Ex19del vs L858R)</p><p><sup>&Dagger;</sup>Pike estimator</p><p><sup>&sect;</sup>Stratified log-rank test</p><p><sup>&para;</sup>Confirmed responses</p><p>&nbsp;</p><p>Figure 4. Kaplan-Meier Curves of PFS by Investigator Assessment in FLAURA</p><p><img src="data:image/jpeg;base64,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" alt="" width="1299" height="800" vspace="0" hspace="0" border="0" style="width:1299px;height:800px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p dir="ltr">&nbsp;</p><p>In a supportive analysis of PFS according to blinded independent central review (BICR), median PFS was 17.7&nbsp;months in the TAGRISSO arm compared to 9.7&nbsp;months in the EGFR TKI comparator arm (HR=0.45; 95% CI: 0.36, 0.57).</p><p>&nbsp;</p><p>Figure 5. Kaplan-Meier Curves of Overall Survival in FLAURA</p><p><img src="data:image/jpeg;base64,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" alt="" width="1301" height="818" vspace="0" hspace="0" border="0" style="width:1301px;height:818px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p>&nbsp;</p><p>Of 556 patients, 200 patients (36%) had baseline brain scans reviewed by BICR; this included 106 patients in the TAGRISSO arm and 94 patients in the investigator choice of EGFR TKI arm. Of these 200 patients, 41 had measurable CNS lesions per RECIST v1.1. Results of pre-specified exploratory analyses of CNS ORR and duration of response (DoR) by BICR in the subset of patients with measurable CNS lesions at baseline are summarized in Table 16.</p><p>&nbsp;</p><p>Table 16. CNS ORR and DOR by BICR in Patients with Measurable CNS Lesions at Baseline in FLAURA</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td><td style="vertical-align:top"><p><strong>TAGRISSO</strong></p><p>N=22</p></td><td style="vertical-align:top"><p><strong>EGFR TKI</strong></p><p><strong>(gefitinib or erlotinib)</strong></p><p>N=19</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>CNS Tumor Response Assessment<sup>*,&dagger;</sup></strong></p></td></tr><tr><td style="vertical-align:top"><p>CNS ORR, % (95% CI)</p></td><td style="vertical-align:top"><p>77 (55, 92)</p></td><td style="vertical-align:top"><p>63 (38, 84)</p></td></tr><tr><td><p>&nbsp; Complete response, %</p></td><td><p>18</p></td><td><p>0</p></td></tr><tr><td colspan="3"><p><strong>CNS Duration of Response<sup>&Dagger;</sup></strong></p></td></tr><tr><td><p>&nbsp; Number of responders</p></td><td style="vertical-align:top"><p>17</p></td><td style="vertical-align:top"><p>12</p></td></tr><tr><td><p>&nbsp; Response Duration &ge;6 months, %</p></td><td style="vertical-align:top"><p>88</p></td><td style="vertical-align:top"><p>50</p></td></tr><tr><td><p>&nbsp; Response Duration &ge;12 months, %</p></td><td style="vertical-align:top"><p>47</p></td><td style="vertical-align:top"><p>33</p></td></tr></tbody></table><p><sup>*</sup>According to RECIST v1.1.</p><p><sup>&dagger;</sup>Based on confirmed response.</p><p><sup>&Dagger;</sup>Based on patients with response only; DoR defined<sup> </sup>as the time from the date of first documented response (complete response or partial response) until progression or death event.</p><p>Previously Untreated EGFR Mutation-Positive Locally Advanced or Metastatic NSCLC<!--[if supportFields]><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_30a438e8-310d-4ce0-b422-e73f35280472 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>FLAURA2 &ndash; TAGRISSO in Combination with Pemetrexed and Platinum-based Chemotherapy</p><p>The efficacy of TAGRISSO in combination with pemetrexed and platinum-based chemotherapy was demonstrated in a randomized, multicenter, open-label trial (FLAURA2 [NCT04035486]) in patients with EGFR exon 19 deletion or exon 21 L858R mutation-positive locally advanced or metastatic NSCLC, who had not received previous systemic treatment for advanced disease. Patients were required to have measurable disease per RECIST v1.1, a WHO performance status of 0-1, and EGFR exon 19 deletions or exon 21 L858R mutations as identified by the cobas<sup>&reg;</sup> EGFR Mutation Test v2 performed prospectively in tissue samples in a central laboratory or by a local test performed in a CLIA-certified or accredited laboratory.</p><p>Patients were randomized (1:1) to one of the following treatment arms:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TAGRISSO (80 mg) orally once daily with pemetrexed (500 mg/m<sup>2</sup>) and investigator&rsquo;s choice of cisplatin (75 mg/m<sup>2</sup>) or carboplatin (AUC5) administered intravenously on Day 1 of 21-day cycles for 4 cycles, followed by TAGRISSO (80 mg) orally once daily and pemetrexed (500&nbsp;mg/m<sup>2</sup>) administered intravenously every 3 weeks</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; TAGRISSO (80 mg) orally once daily</p><p>&nbsp;</p><p>Randomization was stratified by race (Chinese/Asian, non-Chinese/Asian or non-Asian), WHO performance status (0 or 1), and method for tissue testing (central or local). Patients received study therapy until intolerance to therapy, or the investigator determined that the patient was no longer experiencing clinical benefit.</p><p>&nbsp;</p><p>Progression-free survival, as assessed by investigator per RECIST 1.1 was the primary efficacy outcome measure. Overall survival was a key secondary outcome measure. Additional efficacy outcome measures included ORR and DoR.</p><p>&nbsp;</p><p>A total of 557 patients were randomized to either TAGRISSO in combination with pemetrexed and platinum-based chemotherapy (n=279) or TAGRISSO monotherapy (n=278). The median age was 61 years (range 26-85 years); 39% were &ge;65 years and 8% were &ge;75 years of age; 61% were female; 64% were Asian and 66% were never smokers. Baseline WHO PS was 0 (37%) or 1 (63%); 4% had locally advanced and 96% had metastatic NSCLC; and 1.8% received prior systemic cytotoxic chemotherapy as neoadjuvant or adjuvant therapy. With regard to EGFR tumor testing, 61% of tumors had exon 19 deletions and 38% had exon 21 L858R mutations; 0.7% of patients had tumors with both exon 19 deletions and exon 21 L858R. EGFR mutation status was centrally confirmed using the cobas<sup>&reg;</sup> EGFR Mutation Test v2 in 96% of patients.</p><p>&nbsp;</p><p>FLAURA2 demonstrated a statistically significant improvement in PFS for patients randomized to TAGRISSO in combination with pemetrexed and platinum-based chemotherapy as compared to TAGRISSO monotherapy (see Table 17 and Figure 6). While OS results were immature at the current analysis, with 45% of pre-specified deaths for the final analysis reported, no trend towards a detriment was observed.</p><p>&nbsp;</p><p>Table 17. Efficacy Results in FLAURA2 according to Investigator Assessment</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><thead><tr><td style="vertical-align:top"><p><strong>Efficacy Parameter</strong></p></td><td style="vertical-align:top"><p><strong>TAGRISSO with pemetrexed and platinum-based chemotherapy</strong></p><p><strong>(N=279)</strong></p></td><td style="vertical-align:top"><p><strong>TAGRISSO</strong></p><p><strong>(N=278)</strong></p></td></tr></thead><tbody><tr><td colspan="3"><p><strong>Progression-Free Survival (PFS)</strong><sup>#</sup></p></td></tr><tr><td><p>PFS events (%)</p></td><td><p>120 (43)</p></td><td><p>166 (60)</p></td></tr><tr><td><p>Progressive disease (%)</p></td><td><p>95 (34)</p></td><td><p>158 (57)</p></td></tr><tr><td><p>Death<sup>*</sup> (%)</p></td><td><p>25 (9)</p></td><td><p>8 (2.9)</p></td></tr><tr><td><p>Median PFS in months (95% CI)<sup>&thorn;</sup></p></td><td><p>25.5 (24.7, NE)</p></td><td><p>16.7 (14.1, 21.3)</p></td></tr><tr><td><p>Hazard Ratio (95% CI)<sup>&dagger;,&Dagger;</sup></p></td><td colspan="2"><p>0.62 (0.49, 0.79)</p></td></tr><tr><td><p>p-value<sup>&dagger;,&sect;</sup></p></td><td colspan="2"><p>&lt;0.0001</p></td></tr><tr><td colspan="3"><p><strong>Overall Response Rate (ORR)</strong><sup>&para;,#</sup></p></td></tr><tr><td><p>ORR, % (95% CI)</p></td><td><p>77 (71, 82)</p></td><td><p>69 (63, 74)</p></td></tr><tr><td><p>Complete response, %</p></td><td><p>0.4</p></td><td><p>0.4</p></td></tr><tr><td><p>Partial response, %</p></td><td><p>76</p></td><td><p>68</p></td></tr><tr><td colspan="3"><p><strong>Duration of Response (DoR)</strong><sup>&para;</sup></p></td></tr><tr><td><p>Median in months (95% CI)</p></td><td><p>24.9 (22.1, NE)</p></td><td><p>17.9 (15.2, 20.9)</p></td></tr></tbody></table><p>NE=Not Estimable; NR=Not Reached</p><p><sup>#</sup>PFS and ORR results by BICR were consistent with those reported via investigator assessment.</p><p><sup>*</sup>Without documented radiological disease progression.</p><p><sup>&dagger;</sup>Stratified by race (Chinese/Asian, non-Chinese/Asian vs non-Asian), WHO performance status (0 or 1) and method of tissue testing (central or local).</p><p><sup>&Dagger;</sup>Pike estimator.</p><p><sup>&sect;</sup>Stratified log-rank test.</p><p><sup>&para;</sup>Confirmed responses.</p><p>&nbsp;</p><p>Figure 6. Kaplan-Meier Curves of PFS by Investigator Assessment in FLAURA2</p><p><img src="data:image/jpeg;base64,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" alt="" width="1421" height="920" vspace="0" hspace="0" border="0" style="width:1421px;height:920px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p dir="ltr">&nbsp;</p><p>All patients had available baseline brain scans reviewed by BICR using modified RECIST; 78/557 (14%) patients had CNS measurable lesions. Results of pre-specified exploratory analyses of CNS ORR and DoR by BICR are summarized in Table&nbsp;18.</p><p>&nbsp;</p><p>Table 18. Exploratory Analysis &ndash; CNS Efficacy by BICR in Patients with CNS Metastases on a Baseline Brain Scan in FLAURA2</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td rowspan="2" style="vertical-align:bottom"><p><strong>Efficacy Parameter</strong></p></td><td colspan="2" style="vertical-align:top"><p><strong>CNS Measurable Lesions</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>TAGRISSO with pemetrexed and platinum-based chemotherapy</strong><br /><strong>(N=40)</strong></p></td><td style="vertical-align:top"><p><strong>TAGRISSO</strong><br /><strong>(N=38)</strong></p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>CNS Tumor Response Assessment<sup>*,</sup></strong><sup>&dagger;</sup></p></td></tr><tr><td style="vertical-align:top"><p>CNS ORR, % (95% CI)</p></td><td><p>80 (64, 91)</p></td><td><p>76 (60, 89)</p></td></tr><tr><td><p>Complete response, %</p></td><td><p>48</p></td><td><p>16</p></td></tr><tr><td><p>Partial response, %</p></td><td><p>33</p></td><td><p>61</p></td></tr><tr><td colspan="3"><p><strong>CNS Duration of Response<sup>&dagger;,&Dagger;</sup></strong></p></td></tr><tr><td><p>Number of responders</p></td><td style="vertical-align:top"><p>32</p></td><td style="vertical-align:top"><p>29</p></td></tr><tr><td><p>Response Duration &ge;6&nbsp;months, %</p></td><td style="vertical-align:top"><p>75</p></td><td style="vertical-align:top"><p>50</p></td></tr><tr><td><p>Response Duration &ge;12&nbsp;months, %</p></td><td style="vertical-align:top"><p>65</p></td><td style="vertical-align:top"><p>34</p></td></tr></tbody></table><p><sup>*</sup>According to RECIST v1.1.</p><p><sup>&dagger;</sup>Based on confirmed response.</p><p><sup>&Dagger;</sup>Based on patients with response only; DoR defined<sup> </sup>as the time from the date of first documented response (complete response or partial response) until progression or death event.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Previously Treated EGFR T790M Mutation-Positive Metastatic NSCLC<!--[if supportFields]><span
style='mso-element:field-begin'></span> DOCVARIABLE
vault_nd_cbda9feb-bdea-4b69-b757-4b148130b9b2 \* MERGEFORMAT <span
style='mso-element:field-separator'></span><![endif]-->&nbsp;<!--[if supportFields]><span style='mso-element:
field-end'></span><![endif]--></p><p>The efficacy of TAGRISSO was demonstrated in a randomized, multicenter open-label, active-controlled trial in patients with metastatic EGFR T790M mutation-positive NSCLC who had progressed on prior systemic therapy, including an EGFR TKI (AURA3). All patients were required to have EGFR T790M mutation-positive NSCLC identified by the cobas<sup>&reg;</sup> EGFR Mutation Test performed in a central laboratory prior to randomization.</p><p>A total of 419 patients were randomized 2:1 to receive TAGRISSO (n=279) or platinum-based doublet chemotherapy (n=140). Randomization was stratified by ethnicity (Asian vs non-Asian). Patients in the TAGRISSO arm received TAGRISSO 80&nbsp;mg orally once daily until intolerance to therapy, disease progression, or investigator determination that the patient was no longer benefiting from treatment. Patients in the chemotherapy arm received pemetrexed 500&nbsp;mg/m<sup>2</sup> with carboplatin AUC5 or pemetrexed 500 mg/m<sup>2</sup> with cisplatin 75&nbsp;mg/m<sup>2</sup> on Day 1 of every 21-day cycle for up to 6 cycles. Patients whose disease had not progressed after four cycles of platinum-based chemotherapy could have received pemetrexed maintenance therapy (pemetrexed 500&nbsp;mg/m<sup>2</sup> on Day 1 of every 21-day cycle).</p><p>The major efficacy outcome measure was PFS according to Response Evaluation Criteria in Solid Tumors (RECIST v1.1) by investigator assessment. Additional efficacy outcome measures included ORR, DoR, and OS. Patients randomized to the chemotherapy arm who had radiological progression according to both investigator and BICR were permitted to cross over to receive treatment with TAGRISSO.</p><p>The baseline demographic and disease characteristics of the overall trial population were: median age 62 years (range: 20-90 years), &ge;75 years old (15%), female (64%), White (32%), Asian (65%), never smoker (68%), WHO performance status 0 or 1 (100%). Fifty-four percent (54%) of patients had extra-thoracic visceral metastases, including 34% with central nervous system (CNS) metastases (including 11% with measurable CNS metastases) and 23% with liver metastases. Forty-two percent (42%) of patients had metastatic bone disease.</p><p>In AURA3, there was a statistically significant improvement in PFS in the patients randomized to TAGRISSO compared to chemotherapy (see Table 19 and Figure 7). No statistically significant difference was observed between the treatment arms at final OS analysis. At the time of the final OS analysis, 99 patients (71%) randomized to chemotherapy had crossed over to TAGRISSO treatment.</p><p>&nbsp;</p><p>Table 19. Efficacy Results According to Investigator Assessment in AURA3</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><thead><tr><td style="vertical-align:top"><p><strong>Efficacy Parameter</strong></p></td><td style="vertical-align:top"><p><strong>TAGRISSO</strong></p><p><strong>(N=279)</strong></p></td><td style="vertical-align:top"><p><strong>Chemotherapy</strong></p><p><strong>(N=140)</strong></p></td></tr></thead><tbody><tr><td colspan="3"><p><strong>Progression-Free Survival</strong></p></td></tr><tr><td><p>Number of events (%)</p></td><td><p>140 (50)</p></td><td><p>110 (79)</p></td></tr><tr><td><p>Progressive disease (%)</p></td><td><p>129 (46)</p></td><td><p>104 (74)</p></td></tr><tr><td><p>Death<sup>*</sup> (%)</p></td><td><p>11 (4)</p></td><td><p>6 (4)</p></td></tr><tr><td><p>Median PFS in months (95% CI)</p></td><td><p>10.1 (8.3, 12.3)</p></td><td><p>4.4 (4.2, 5.6)</p></td></tr><tr><td><p>Hazard Ratio (95% CI)<sup>&dagger;, &Dagger;</sup></p></td><td colspan="2"><p>0.30 (0.23,0.41)</p></td></tr><tr><td><p>p-value<sup>&dagger;, &sect;</sup></p></td><td colspan="2"><p>&lt;0.001</p></td></tr><tr><td colspan="3"><p><strong>Overall Survival</strong></p></td></tr><tr><td><p>Number of deaths (%)</p></td><td><p>188 (67)</p></td><td><p>93 (66)</p></td></tr><tr><td><p>Median OS in months (95% CI)</p></td><td><p>26.8 (23.5, 31.5)</p></td><td><p>22.5 (20.2, 28.8)</p></td></tr><tr><td><p>Hazard Ratio (95% CI)<sup>&dagger;, &Dagger;</sup></p></td><td colspan="2"><p>0.87 (0.67, 1.12)</p></td></tr><tr><td><p>p-value<sup>&dagger;,</sup><sup>&sect;</sup></p></td><td colspan="2"><p>0.277</p></td></tr><tr><td colspan="3"><p><strong>Overall Response Rate</strong><sup>&para;</sup></p></td></tr><tr><td><p>ORR, % (95% CI)</p></td><td><p>65 (59, 70)</p></td><td><p>29 (21, 37)</p></td></tr><tr><td><p>Complete response, %</p></td><td><p>1</p></td><td><p>1</p></td></tr><tr><td><p>Partial response, %</p></td><td><p>63</p></td><td><p>27</p></td></tr><tr><td><p>p-value<sup>&dagger;,#</sup></p></td><td colspan="2"><p>&lt;0.001</p></td></tr><tr><td colspan="3"><p><strong>Duration of Response (DoR)</strong></p></td></tr><tr><td><p>Median in months (95% CI)</p></td><td><p>11.0 (8.6, 12.6)</p></td><td><p>4.2 (3.0, 5.9)</p></td></tr></tbody></table><p><sup>*</sup>Without documented radiological disease progression</p><p><sup>&dagger;</sup>Stratified by ethnicity (Asian vs non-Asian)</p><p><sup>&Dagger;</sup>Pike estimator</p><p><sup>&sect;</sup>Stratified log-rank test</p><p><sup>&para;</sup>Confirmed Responses</p><p><sup>#</sup>Logistic regression analysis</p><p>&nbsp;</p><p>Figure 7. Kaplan-Meier Curves of PFS by Investigator Assessment in AURA3</p><p><img src="data:image/jpeg;base64,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" alt="" width="623" height="399" vspace="0" hspace="0" border="0" style="width:623px;height:399px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p>&nbsp;</p><p>In a supportive analysis of PFS according to BICR, median PFS was 11&nbsp;months in the TAGRISSO arm compared to 4.2 months in the chemotherapy arm (HR 0.28; 95% CI: 0.20, 0.38).</p><p>Of 419 patients, 205 (49%) had baseline brain scans reviewed by BICR; this included 134 (48%) patients in the TAGRISSO arm and 71 (51%) patients in the chemotherapy arm. Assessment of CNS efficacy by RECIST v1.1 was performed in the subgroup of 46/419 (11%) patients identified by BICR to have measurable CNS lesions on a baseline brain scan. Results are summarized in Table 20.</p><p>&nbsp;</p><p>Table 20. CNS ORR and DoR by BICR in Patients with Measurable CNS Lesions at Baseline in AURA3</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td><td style="vertical-align:top"><p><strong>TAGRISSO</strong></p><p><strong>N=30</strong></p></td><td style="vertical-align:top"><p><strong>Chemotherapy</strong></p><p><strong>N=16</strong></p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>CNS Tumor Response Assessment</strong><sup>*,&dagger;</sup></p></td></tr><tr><td style="vertical-align:top"><p>CNS ORR, % (95% CI)</p></td><td style="vertical-align:top"><p>57 (37, 75)</p></td><td style="vertical-align:top"><p>25 (7, 52)</p></td></tr><tr><td><p>Complete response, %</p></td><td><p>7</p></td><td><p>0</p></td></tr><tr><td colspan="3"><p><strong>Duration of CNS Response<sup>&dagger;,</sup></strong><sup>&Dagger;</sup></p></td></tr><tr><td><p>Number of responders</p></td><td style="vertical-align:top"><p>17</p></td><td style="vertical-align:top"><p>4</p></td></tr><tr><td><p>Response Duration &ge;6 months, %</p></td><td style="vertical-align:top"><p>47</p></td><td style="vertical-align:top"><p>0</p></td></tr><tr><td><p>Response Duration &ge;9 months, %</p></td><td style="vertical-align:top"><p>12</p></td><td style="vertical-align:top"><p>0</p></td></tr></tbody></table><p><sup>*</sup>According to RECIST v1.1.</p><p><sup>&dagger;</sup>Based on confirmed response.</p><p><sup>&Dagger;</sup>Based on patients with response only; DoR defined<sup> </sup>as the time from the date of first documented response (complete response or partial response) until progression or death event.</p><p>&nbsp;</p><p dir="ltr">&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The area under the plasma concentration-time curve (AUC) and maximal plasma concentration (Cmax) of osimertinib increased dose proportionally over 20 to 240 mg dose range (i.e., 0.25 to 3 times the recommended dosage) after oral administration and exhibited linear pharmacokinetics (PK). Administration of TAGRISSO orally once daily resulted in approximately 3-fold accumulation with steady-state exposures achieved after 15 days of dosing. At steady state, the Cmax to Cmin (minimal concentration) ratio was 1.6-fold.</p><p>The pharmacokinetics in patients treated with osimertinib in combination with pemetrexed and platinum-based chemotherapy are similar to those in patients treated with osimertinib monotherapy.</p><p><strong>Absorption</strong></p><p>The median time to Cmax of osimertinib was 6 hours (range 3-24 hours).</p><p>Following administration of a 20 mg TAGRISSO tablet with a high-fat, high-calorie meal (containing approximately 58 grams of fat and 1000 calories), the Cmax and AUC of osimertinib were comparable to that under fasting conditions.</p><p><strong>Distribution</strong></p><p>The mean volume of distribution at steady-state (Vss/F) of osimertinib was 918 L. Plasma protein binding of osimertinib was 95%. PET brain imaging studies in healthy volunteers and in patients with brain metastases show that osimertinib is distributed to the brain following intravenous injection of a micro dose of 11C-labeled osimertinib.</p><p><strong>Elimination</strong></p><p>Osimertinib plasma concentrations decreased with time and a population estimated mean half-life of osimertinib was 48 hours, and oral clearance (CL/F) was 14.3 (L/h).</p><p><strong>Metabolism</strong></p><p>The main metabolic pathways of osimertinib were oxidation (predominantly CYP3A) and dealkylation in vitro. Two pharmacologically active metabolites (AZ7550 and AZ5104) have been identified in the plasma after TAGRISSO oral administration. The geometric mean exposure (AUC) of each metabolite (AZ5104 and AZ7550) was approximately 10% of the exposure of osimertinib at steady-state.</p><p><strong>Excretion</strong></p><p>Osimertinib is primarily eliminated in the feces (68%) and to a lesser extent in the urine (14%). Unchanged osimertinib accounted for approximately 2% of the elimination.</p><p><strong>Specific Populations</strong></p><p>No clinically significant differences in the pharmacokinetics of osimertinib were observed based on age, sex, ethnicity, body weight, baseline albumin, line of therapy, smoking status, renal function (creatinine clearance (CLcr) &ge;15 mL/min by Cockcroft-Gault), or hepatic impairment (Child-Pugh A and B, or total bilirubin &le; ULN and AST &gt; ULN or total bilirubin between 1 to 3 times ULN and any AST). The pharmacokinetics of osimertinib in patients with end-stage renal disease (CLcr &lt;15 mL/min) or severe hepatic impairment (total bilirubin 3 to 10 times ULN and any AST) are unknown [see Use in Specific Populations (8.6) and (8.7)].</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Carcinogenesis, Mutagenesis, Impairment of Fertility</strong></p><p>A 2-year carcinogenicity was conducted in male and female rats at oral osimertinib doses of 1, 3, and 10 mg/kg/day. Osimertinib increased the incidences of hemangioma and combined hemangioma/hemangiosarcoma in the mesenteric lymph node and whole body at 10 mg/kg/day (0.2 times the human exposure based on AUC at the clinical dose of 80 mg once daily). Administration of osimertinib to male and female rasH2 transgenic mice by oral gavage daily for 26 weeks did not result in an increased incidence of neoplasms at doses up to 10 mg/kg/day.</p><p>Osimertinib did not induce mutations in the bacterial reverse mutation (Ames) assay and was not genotoxic in mouse lymphoma cells or in the rat in vivo micronucleus assay.</p><p>Based on studies in animals, male fertility may be impaired by treatment with TAGRISSO. Degenerative changes were present in the testes in rats and dogs exposed to osimertinib for 1 month or more with evidence of reversibility in the rat. Following administration of osimertinib to rats for approximately 10 weeks at a dose of 40 mg/kg, at exposures 0.5 times the AUC observed at the recommended clinical dose of 80 mg once daily, there was a reduction in male fertility, demonstrated by increased pre-implantation loss in untreated females mated to treated males.</p><p>Based on studies in animals, female fertility may be impaired by treatment with TAGRISSO. In repeat dose toxicity studies, histological evidence of anestrus, corpora lutea degeneration in the ovaries and epithelial thinning in the uterus and vagina were seen in rats exposed to osimertinib for 1 month or more at exposures 0.3 times the AUC observed at the recommended clinical dose of 80 mg once daily. Findings in the ovaries seen following 1 month of dosing exhibited evidence of reversibility. In a female fertility study in rats, administration of osimertinib from 2 weeks prior to mating through Day 8 of gestation at a dose of 20 mg/kg/day (approximately 1.5 times the Cmax at the recommended dose of 80 mg once daily) had no effects on estrous cycling or the number of females becoming pregnant, but caused early embryonic deaths. These findings showed evidence of reversibility when females were mated 1 month after treatment discontinuation.</p><p><strong>Animal Toxicology and/or Pharmacology</strong></p><p>Administration of osimertinib resulted in histological findings of lens fiber degeneration in the 2-year rat carcinogenicity study at &ge;3 mg/kg/day (exposures 0.2 times the human exposure based on AUC). These findings were consistent with the ophthalmoscopic observation of lens opacities, which were first noted from week 52 and showed a gradual increase in incidence and severity with increased duration of dosing.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Tablet core</u></p><p>Mannitol Microcrystalline cellulose</p><p>Low-substituted hydroxypropyl cellulose Sodium stearyl fumarate</p><p>&nbsp;</p><p><u>Tablet coating</u></p><p>Polyvinyl alcohol Titanium dioxide (E 171) Macrogol 3350</p><p>&nbsp;</p><p>Talc</p><p>Yellow iron oxide (E 172) Red iron oxide (E 172) Black iron oxide (E 172)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 Months 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">This medicinal product does not require any special storage conditions.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Al/Al perforated unit dose blisters. Cartons of 30 x 1 tablets (3 blisters).</p><p dir="ltr">Al/Al perforated unit dose blisters. Cartons of 28 x 1 tablets (4 blisters).</p><p dir="ltr">Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="ltr">Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AstraZeneca AB
SE-151 85 Södertälje
Sweden
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Oct 2024

            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>